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 Advances in computer hardware have enabled routine MD simulations of 
systems with tens of thousands of atoms for up to microseconds (soon 
milliseconds). The key limiting factor in whether these simulations can advance 
hypothesis testing in active research is the accuracy of the force fields. In 
many ways, force fields for RNA are less mature than those for proteins. Yet 
even the current generation of force fields offers benefits to researchers as we 
demonstrate with our re-refinement effort on two RNA hairpins. Additionally, 
our simulation study of the binding of 2-aminobenzimidazole inhibitors to 
hepatitis C RNA offers a computational perspective on which of the two rather 
different published structures (one NMR, the other X-ray) is a more reasonable 
structure for future CADD efforts as well as which free energy methods are 
suited to these highly charged complexes. Finally, further effort on force field 
improvement is critical. We demonstrate an effective method to determine 
quantitative conformational population analysis of small RNAs using enhanced 
sampling methods. These efforts are allowing us to uncover force field 
pathologies and quickly test new modifications. In summary, this research 
serves to strengthen communication between experimental and theoretical 
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1.1 Themes and Background 
In a broad sense, the goal of the research presented in this dissertation 
is to improve techniques for the theoretical study of RNA structure and 
dynamics as well as to demonstrate the utility of integrating theoretical study 
with experimental data in order to advance hypotheses testing. The research is 
presented from a computational perspective and employs molecular dynamics 
(MD) simulations as the primary theoretical exploration environment. Although 
no experimental data were collected by the author, the evaluation of each 
study in the context of available experimental data is evident. Thus, the aim of 
a deeper, more reliable partnership between theoretical and experimental 
study of RNA becomes the theme throughout this dissertation. Ultimately, the 
work presented here will serve as a stepping stone towards making simulation 
techniques a routine part of studying biochemical systems and developing 
disease treatments. Currently, most RNA directed drugs are antibiotics acting 
on the ribosome while other RNA targets remain largely unstudied (1). We 
anticipate the research in this dissertation will aid in developing RNA into a 
commonplace drug target. 
2 
 
It is important to justify whether MD simulations are in fact the best 
theoretical approach to partner with experimental studies of RNA structure and 
dynamics. While a variety of approaches can be used, MD simulations offer two 
key advantages. First, the system of interest (in this case RNA) is represented 
in atomic detail. Other approaches, in an effort to reduce computational 
expense, might rely on coarse-grained models in which groups of atoms are 
represented by a single particle. As the coarseness increases, the departure 
from a physically realistic representation of the system is also increased. In the 
MD approach, predictions about each atom in system can be made because 
they are physically represented. Of course, the MD approach is itself an 
approximation. Rather than explicitly representing the electronic structure of 
atoms through wave functions (i.e., quantum mechanics), the system is treated 
in classical physics approach wherein each atom is represented by a particle 
and the forces between particles are governed by Newton’s equations of 
motion. This approximation leads to the second key advantage of MD 
simulations. Quantum mechanical calculations are extremely expensive 
computationally and are typically employed only to perform “snapshot” energy 
analysis on small systems rather than to propagate system dynamics over time. 
In contrast, the approximations used in MD simulations allow for the simulation 
of thousands to hundreds of thousands of atoms on timescales of tens of 
nanoseconds up to milliseconds. On these timescales, dynamic properties such 
as hinge-flexing, folding, and reorganization processes can be studied. The 
range and size of such processes is expected to increase as computer power 
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increases in the future. In summary, MD simulations appear to be ideally 
situated (given current computational resources) to provide atomic detail of 
biochemical system dynamics. 
1.2 A Brief History of RNA MD Simulations 
MD simulations are useful in studying biochemical systems because they 
fill a critical void in experimental data. Just as it might be difficult to fully 
understand how an internal combustion engine works if one only studied an 
inoperable engine, biochemistry is difficult to fully understand without an 
understanding of the system dynamics. For instance, although X-ray 
crystallography provides exquisite atomic level detail of biochemical systems, 
the constraints of the uniform crystal lattice make it difficult to study the 
dynamics necessary for biochemistry (for example, an enzymatic reaction). 
Other experimental techniques, such as nuclear magnetic resonance, circular 
dichroism, small angle X-ray scattering and others provide partial or indirect 
information about system dynamics, but bridging that data with an atomistic 
understanding requires some level of interpretation. MD simulations have 
increasingly performed this role over the last ten to fifteen years and can be 
expected to be more important in the future. 
The quality of MD force fields, which are the parameters that dictate 
the classical physics interactions of atom in a simulation, are generally thought 
to be more mature for proteins than RNA. For example, recent MD simulations 
have provided deep insight into protein folding (2-8), protein dynamics (9, 10), 
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ligand-receptor interactions (11-14), and structure-function relationships (15). 
Achieving reliability for RNA force fields appears to be more challenging. When 
comparing protein structure with RNA structure, a variety of potential 
explanations are found. First, RNA is generally extremely flexible and dynamic 
which is likely an outgrowth of the large number of flexible torsion angles in 
the polymeric backbone (Figure 1.1) which adopt a variety of conformational 
suites (16). Second, because RNA is a poly-anion, its structure is inherently 
coupled with water and ions and thus simulation accuracy is likely highly 
dependent on both RNA and solvent parameters. Third, RNA structure tends to 
be more linear than proteins, which are often globular, resulting in greater 
solvent exposure. This potentially complicates parameterization of force fields 
because the parameters must be simultaneously accurate in the context of 
both an RNA environment and a solvent environment. These difficulties are 
being addressed over time and current force fields are more reliable than ever.  
It is instructive to give a brief overview on the progress of RNA MD 
simulations over the last twenty years. Prior to the mid-1990s, MD simulations 
were not only very short (on the picosecond timescale) but also unreliable. 
Simulations were often used with experimental restraints for structure 
refinements. Stable, unrestrained simulations of RNA were difficult until more 
accurate treatment of long distance charge interactions were introduced in the 
mid-1990s (17). At the time, the simulations were on the order of one 
nanosecond, making reliable comparisons with experiment difficult. Examples 
of studies performed at this time included predicting loop geometries (18, 19), 
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studying RNA-protein complexes in bound and unbound states (20-22), and 
identifying sequence specific dynamics (23). As computer power advanced in 
the early 2000s, the depth of analysis did too with simulations typically on the 
order of one to twenty nanoseconds. Studies at this time included the dynamics 
of RNA-protein systems (24-27), deeper study of structure flexibility and base 
pair dynamics (28-33), identification of solvent structure features including ion 
pockets (34-38), diffusion studies (39), and RNA-ligand binding (40). For the 
most part, recent studies have expanded these approaches in an increasing 
variety of different systems. However, progress has been made to push the 
boundaries of what is achievable in terms of system size and timescale. In 
addition, the use of advanced algorithms for sampling, free energy analysis, 
and combination of quantum mechanics with MD have become feasible and 
commonplace. Examples of such literature include studies of RNA enzymes and 
riboswitches (41-46), simulations of a complete, solvated virus (47), folding and 
conformational ensemble studies of RNA hairpins (48-50), constant pH 
simulations (51, 52), and insight into RNA-protein complex cooperativity (53).  
Throughout this time, defects in the MD force fields of RNA (presumably 
due to the approximate nature of the parameters) have been uncovered and 
subsequent corrections have been shown to improve simulation results with 
respect to experimental data. All the research presented in this dissertation 
uses the AMBER simulation software and force fields (54) for which a number of 
force field improvements have been made over the years (55-61). Considerable 
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effort has also been put into evaluating and improving the CHARMM 
biomolecular software (62) RNA force field as well (63-65). 
Taken together, the research in this dissertation seeks to build on 
previous efforts in RNA simulation, both in terms of offering insight into RNA 
structure and dynamics as well as developing methods to improve the quality of 
RNA force fields. In Chapter 2, we describe how explicitly solvated MD 
simulations offer a consensus picture of domain 5 of two group II introns. In 
Chapter 3, we report computational studies on the binding of several small-
molecule inhibitors to hepatitis C viral RNA and our investigations into the 
differences in the available experimental structures of the RNA-inhibitor 
complex. In Chapter 4, we describe enhanced sampling techniques on a small 
RNA tetranucleotide and introduce a protocol for quantitatively identifying 
violations of experimental data due to force field errors. Finally, in the 










Figure 1.1  Complexity of the RNA dinucleotide structural unit. The 
backbone torsion angles are indicated in Greek letters. Figure adapted from 
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MOLECULAR DYNAMICS RE-REFINEMENT OF TWO DIFFERENT  
SMALL RNA LOOP STRUCTURES USING THE ORIGINAL  
NMR DATA SUGGEST A COMMON STRUCTURE 
 
2.1 Chapter Notes 
 This chapter was adapted from the following published article:  
Niel M. Henriksen, Darrell R. Davis, Thomas E. Cheatham III. 
Molecular dynamics re-refinement of two different small RNA loop 
structures using the original NMR data suggest a common 
structure. Journal of Biomolecular NMR. 2012. 53(4) 321-339.  
 
N.M. Henriksen and T.E. Cheatham, III designed the research. N.M. Henriksen 
performed the research. N.M. Henriksen wrote the manuscript. N.M. Henriksen, 
D.R. Davis, and T.E. Cheatham, III revised the manuscript.  
2.2 Introduction 
 Molecular dynamics (MD) simulations are often used with restraints 
derived from crystallography or nuclear magnetic resonance (NMR) experiments 
for the end-stage atomistic refinement of biological macromolecular structures 
(1-5). Quite commonly, rather quick and standard MD refinement protocols are 
employed using codes such as X-PLOR (6), XPLOR-NIH (7, 8) or CNS (9, 10). A 
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refinement protocol might initiate a search for restraint-compatible structures 
via simulated annealing or distance geometry methods followed by very short 
(20-200 picosecond) gas-phase MD simulations with applied restraints to further 
relax and refine the structures. In these refinement protocols, often the force 
field—specifically the molecular mechanical parameters and force constants 
that define the covalent connectivity and atomic pair interactions—is rather 
simplified or crude and the MD simulations are performed in vacuo in the 
absence of solvent and mobile counter-ions. Despite the limitations of these 
simplified force fields, excellent results are generally obtained given a 
sufficiently robust set of experimentally derived data. This latter point is 
somewhat obvious noting that, if sufficient data from experiment has been 
collected to define the structure, the force field should not strongly influence 
or bias the results as the structure should be largely determined by the 
experimental data. However, when the experimental data are sparse, the 
structure is dynamic, or when solvent and mobile ions may be critically 
important elements of the structure, the arguably simple force fields and/or 
absences of experimental restraint data may lead to “loose” structure 
ensembles. These loose ensembles may suggest larger ranges of motion where 
data were absent and/or populate anomalous structures leading to an incorrect 
interpretation of the structure. A logical step to make up for missing data is to 
apply optimized biomolecular force fields in MD simulations with explicit 
solvent and modern simulation protocols. A relevant example involves the 
refinement of nucleic acid structures from NMR data, particularly in the 
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absence of residual dipolar coupling (RDC) information, where long-range 
restraint information is absent (11). If the force field and simulation protocols 
are reasonably robust and ideally experimentally validated, they together with 
the experimentally derived restraint information should provide a better 
representation of the structure. Although NMR refinement using modern MD 
simulation protocols with experimentally derived restraints, optimized force 
fields for proteins and nucleic acids, and explicit solvent suggests this to be 
true (12-18), such methods are not widely or routinely applied. For example, in 
recent years only a handful of NMR structures have been refined in explicit 
solvent using optimized force fields and modern simulation protocols, and 
these include the structure elucidation of a peptide (19), an RNA hairpin (20), a 
DNA naphthalimide adduct (21), a designed metalloprotein (22), and an RNA 
receptor/ligand complex (23). 
Although refinement of NMR structures using modern force fields and 
simulation protocols, including explicit solvent, appears to produce structures 
that provide excellent fits to the experimental data, these approaches are not 
without limitation. Complications relate to dynamics, the time scales of the 
dynamics, and whether these motions are even accessible on the timescale 
sampled during the molecular dynamics refinement. Moreover, RNA may 
populate multiple conformations under the given set of experimental 
conditions (24-28). With traditional refinement, high restraint weights may 
lead to structural representations that are too tight, that hide dynamics, and 
that limit potential transformations between multiple conformations (29). 
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Essentially, an average structure will be found that may not entirely satisfy all 
of the experimental data. Procedures such as time-averaged restraints (30-32), 
selective enforcement of restraints over time (33), or ensemble based 
refinement methods (34, 35) may help mitigate these issues. However, these 
methods will further depend on the reliability of the force field representation 
to correctly sample the accessible conformational space. Ultimately, given a 
reliable and validated force field, the molecular dynamics simulations without 
experimental restraints starting from the refined NMR structure should provide 
an accurate representation of the structure and dynamics over the simulation 
time scale. However, the force fields are not yet fully reliable, especially in 
the treatment of RNA (36-40). Therefore, at present, there needs to be a 
careful balance between the relative weights of the force field compared to 
the experimental or structural restraints, with further care levied to 
understand the limitations of the force fields and implications of specific 
restraint choices. 
In this work we further assess the reliability of more detailed MD 
structure refinement protocols through the re-refinement of two similar RNA 
molecules. As part of our larger force field assessment efforts, we have been 
investigating a variety of RNA structures in free, unrestrained MD simulation to 
better understand the reliability and flaws of the AMBER nucleic acid force 
fields (40-46) as compared to available experimental data. Ideal RNA structures 
for our investigation include those which display some noncanonical structure 
(i.e., nonhelical structure since the AMBER force fields appear to do a 
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reasonable job of modeling nucleic acid helices (47-53)) and importantly, 
structures where detailed NMR restraint information is available including NOE 
derived distance, J-coupling and RDC restraints. Our explorations led us to two 
published RNA structures that have nearly identical primary sequence, yet the 
published 3D structures differ significantly. 
A comprehensive MD investigation of these two previously refined RNA 
structures from the PDB (54) was performed, specifically on structures with the 
PDB codes of 1R2P (55) and 2F88 (56). These structures consist of a 34 residue 
segment derived from domain 5 (D5) of the group IIB intron ribozyme in yeast 
ai5γ (55) (ai5γ-D5) and Pylaiella littoralis (56) (PL-D5), respectively. Domain 5 
serves an essential role in the core of the intron structure and contains the 
most important residues for catalysis (57). The primary sequence of ai5γ-D5 
and PL-D5 is mostly identical, except for three residues (Figure 2.1, noting the 
different boxed residues 8, 25, and 27). The structural elements of both D5s 
include a lower helix joined by a bulge region to an upper helix that is capped 
by a GAAA tetraloop (shown in Figure 2.1 in red, green, blue, and pink, 
respectively). Residues A2, G3, and C4 form what is known as the catalytic 
triad; this is a highly conserved region of interest noted for forming tertiary 
interactions and interactions with Mg2+. According to the published structures, 
the conformation of the bulge region differs depending both on the sequence 
and experimental method (NMR vs. X-ray crystallography), while the lower 
helix, upper helix, and tetraloop features are all very similar. The bulge 
conformation as reported in the earlier crystal structure of ai5γ-D5 (PDB: 1KXK) 
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(58) shows G26 forming a wobble pair with U9, while A24 and C25 are unpaired 
and opened away from the helix. In contrast, the NMR structures of ai5γ-D5 
and PL-D5 (referred to as ai5γ_NMR and PL_NMR from here on) both suggest 
that G26 is in a syn conformation that protrudes into the major groove. 
However, the positioning of the other bulge residues differs between the two 
NMR structures: while most of the ai5γ_NMR ensemble structures show residues 
24 and 25 stacked into a narrow helix above U9, the PL_NMR structures show 
residues 24 and 25 in one of two conformations opposite, but not directly 
interacting with, U9. Both of these conformations of PL_NMR show a very wide 
bulge region accommodating A25 either stacked into the helix below A24 (as is 
shown in Figure 1.1, right) or packed against the minor groove out of the helix. 
The differences in these bulge structures are highlighted in the supporting 
information using molecular graphics (Figure 2.2) and annotated secondary 
structure representations (Figure 2.3). We note that the expected 
conformation of the bulge in the context of the full intron likely does not 
resemble any of the earlier X-ray or NMR structures. Despite sequence 
differences, the bulge conformation in the full intron will probably be similar 
to the more recent X-ray structures of the full Oceanobacillus iheyensis self-
spliced group IIC intron where tertiary interactions stabilize a different bulge 
conformation (PDBs: 3BWP, 3EOG, 3EOH, and 3IGI) (59, 60). Collectively, the 
various bulge conformations observed in the earlier NMR and crystal structures, 
and those we report upon re-refinement, suggest that the bulge structure 
clearly differs when in an isolated solution environment, is influenced by 
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sequence, crystal packing and tertiary packing, and is likely dynamic. Except 
for the bulge region, most of the other elements of the D5 structure are quite 
similar between ai5γ_NMR and PL_NMR. One remaining difference is the overall 
structural length of D5. The structures of ai5γ_NMR are more extended while 
those of PL_NMR are compact and similar in length to the X-ray structure of 
ai5γ-D5. The other difference of significance between the published studies 
relates to the determination of divalent ion binding as determined by NMR 
chemical shift perturbations upon addition of MgCl2. It was not obvious to us 
whether real differences in ion binding or structure exist between the RNA 
constructs, or whether the published observations reflect subtle differences in 
NMR methods and/or experimental conditions, despite apparently strong 
similarities in the experiments and refinement protocols. 
Together, these two structures and their previously accumulated and 
published data (chemical shifts, restraints, and chemical shift perturbations) 
provide an intriguing opportunity to validate the MD simulations, to assess 
simulation refinement protocols which use explicit solvent and modern force 
fields, and to ultimately determine whether the significant differences in these 
structures reported are real or artifacts from the refinement process. We show 
that re-refinement leads to two very similar structures that appear to better 
satisfy the NMR data. In addition, beyond the bulge region (which is strongly 
influenced by packing effects and tertiary interactions), the stem and loop 
regions around the bulge better match the ai5γ-D5 (PDB: 1KXK) crystal 
structure than the previously published NMR structures. Yet, the results also 
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suggest that a careful balance between relative weights of the force field 
compared to the experimental data is required, that the experimental data 
have to be carefully screened, that there are clear sampling limitations, and 
that there are still known and emerging force field limitations. Taken together, 
these observations preclude the use of automation to automatically refine 
structures. The previous and current success of these methods suggest that 
some published structures might be improved using explicit solvent MD 
refinements and that such techniques should be more routinely applied in 
future structure refinement projects. 
2.3 Methods 
2.3.1 Coordinates and restraint data 
 The coordinates and restraint data for the ai5γ_NMR and PL_NMR 
structures were retrieved from the RCSB Protein Data Bank website using the 
PDB codes 1R2P and 2F88, respectively. Of the ten conformers contained in 
each PDB file, only the first five were used in simulations. The distance 
restraint data were thoroughly checked for atom naming mismatches between 
the restraint file and the PDB files. Mismatched restraints were corrected 
based on visual inspection of the structures (common mismatches included H62 
→ H61 or H5’1 → H5’2 transpositions). Distance restraints were weighted at 20 
kcal/mol-Å within 0.5 Å of the bounds of the flatwell restraint and at 20 
kcal/mol-Å2 outside this range, unless otherwise noted. The applied dihedral 
restraint data from the two earlier refinements were consolidated and 
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reconfigured to produce a more consistent and liberal set of dihedral restraints 
and also to eliminate minor differences in the conventions used by the 
ai5γ_NMR and PL_NMR authors. Backbone torsions of the helical regions 
(torsions 1:γ – 8:γ, 10:ε – 14:γ, 19:ε – 23:γ, 27:ε-34:ε) were restrained to A-
form values (± 15°) while those in the remaining noncanonical regions were left 
unrestrained. The χ torsion angle was restrained to syn (70 ± 30°) for G26 and 
anti (-160 ± 15°) for all others. Sugar puckers were restrained (i.e., torsions δ, 
ν1, and ν2) in a similar manner as described in the original publications: for 
ai5γ-D5, A16 and C25 were restrained to C2’-endo, whereas G15, A17, and A18 
were unrestrained, and the remaining were restrained to C3’-endo; for PL-D5, 
A16, A24, and A25 were restrained to C2’-endo, and the remaining were 
restrained to C3’-endo. Torsion restraints were weighted at 500 kcal/mol-rad 
within 1° of the bounds of the flatwell restraint and at 500 kcal/mol-rad2 
outside this range, unless otherwise noted. Relative RDC restraint weighting, 
set with the “dwt” keyword in AMBER, was chosen to be the highest value that 
did not cause SHAKE errors during simulation (dwt=0.02 for ai5γ-D5, dwt=0.01 
for PL-D5). Base pair planarity restraints were not applied. All restraints were 
converted to the AMBER formats using in-house scripts and scripts available in 




2.3.2 Building, heating, and equilibrating solvated structures 
All MD simulations were performed using the AMBER and AmberTools 
suites of software (61, 62). The PDB structures were parameterized using the 
AMBER ff99bsc0 (44) force field, and were solvated in an icosahedral TIP3P (63) 
water box out to at least 10 Å in each direction from the solute followed by 
net-neutralization with Na+ ions and addition of ~200 mM NaCl using the Joung 
and Cheatham ion parameters (64, 65). The Na+ cation was chosen for initial 
investigations due to the salt crystallization artifacts seen with the earlier K+ 
parameters (66), despite the fact that K+ was used in the NMR buffer. The Na+ 
cation was used throughout this work, albeit with the improved parameters, in 
order to maintain consistency with our older data. In total, the solvated 
systems contained between 9000 – 12000 residues, corresponding to 
approximately 29000 – 37000 atoms. After building the coordinate and 
parameter/topology (prmtop) files, the positions of all the ions in the 
coordinate files were randomized using ptraj, ensuring that ions were at least 6 
Å from an RNA atom and 4 Å from each other. The particle mesh Ewald method 
(67) was used to handle electrostatic interactions using a 9 Å cutoff with 
default parameters (including an ~1 Å grid spacing, cubic spline interpolation, 
and a direct space cutoff tolerance of 0.000001). Lennard-Jones interactions 
were also treated with a 9 Å cutoff and the pairlist built to 10 Å was 
automatically rebuilt if any atom moved more than 0.5 Å since the previous 
update. Each system was first relaxed with 1000 steps each of steepest descent 
and conjugate gradient minimization while RNA atom positions were restrained 
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with 25 kcal/mol-Å2 positional restraints. Continuing with the same positional 
restraints, the system was slowly heated from 100 K to 300 K over the course of 
100 ps at constant volume. After heating, the system was repeatedly minimized 
(1000 steps each, steepest descent and conjugate gradient) and equilibrated at 
constant pressure (for 50 ps each round) using gradually weaker positional 
restraints (5.0, 4.0, 3.0, 2.0, 1.0, and 0.5 kcal/mol-Å2). For restrained 
simulations, distance and torsion restraints as previously described were 
enforced during each step of the equilibration process. A final equilibration 
step for the restrained simulations was included following the 0.5 kcal/mol-Å2 
position restrained equilibration. This step consisted of a relaxation period of 2 
ns at constant pressure without positional restraints and with distance and 
torsion restraints at 10% of normal strength. 
2.3.3 Restrained production simulations 
Production simulations were performed at constant pressure and 
temperature using the Berendsen algorithm (68) for scaling. The heat bath and 
pressure coupling time constants were set to a loose value of 5 ps. Chemical 
bonds to hydrogen atoms were constrained using the SHAKE algorithm (69, 70), 
which permitted a time step of 2 fs for production simulations. Translational 
and rotational center-of-mass motion was removed every 500 steps. 
Coordinates of the system were recorded every picosecond during simulation. 
Distance/torsion angle (DA) restrained simulations were performed using the 
AMBER’s PMEMD program. Restrained simulations using distance/torsion-
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angle/RDC (DAR) restraints were performed using AMBER’s sander program 
(PMEMD is generally faster than sander however PMEMD does not yet implement 
RDC restraints). DAR restrained simulations were not started from an 
independent equilibration, but rather were started from the final frame of the 
corresponding DA restrained simulation. To accomplish this, the RDC alignment 
tensor was first minimized to best fit the RNA structure. Then the DAR 
simulation was started using the tensor values obtained in the minimization. 
Every time a DAR simulation was restarted, the alignment tensor values were 
obtained from the final step of the previous output file and used as the starting 
values for the next calculation. A complete listing of the simulations is given in 
Table 2.1, noting that the five independent runs originated from the first five 
representative NMR structures from the 1R2P and 2F88 PDB files. 
The structure refinement protocol presented here significantly extends 
the procedure used to generate the ai5γ_NMR (55) and PL_NMR (56) structures. 
Specifically, significantly longer MD simulations were performed including 
explicit solvent and mobile counterions, modern force fields, and proper 
treatment of the long range electrostatic interactions. Longer simulation, and 
in some case heating, provided significantly more sampling of potential RNA 
structure and helped identify where structures may have otherwise been 
trapped due to previously insurmountable barriers. In contrast, both earlier 
publications report using CNS to generate an extended structure, followed by 
the selection of 100 starting structures generated from different random initial 
velocities. The starting structures were relaxed using high-temperature, 
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torsion-angle dynamics, slow cooling using distance and angle restrained 
molecular dynamics, and minimization. Total molecular dynamics for each 
structure in the earlier refinement protocols did not exceed 250 ps. The 
PL_NMR structures were then further refined based on the RDC data using a 
more extensive protocol. 
2.3.4 Analysis 
All PDB and trajectory structures were visualized using UCSF Chimera 
(71). Structure snapshots were also generated using Chimera. RMSD values were 
generated using AMBER’s ptraj module and results were plotted using Grace 
(72) or Microsoft Excel. Distance and dihedral measurements were calculated 
and analyzed using ptraj and in-house scripts. Clustering was performed in 
ptraj (73) using the following settings: average-linkage algorithm, cluster count 
set to 5, rms similarity metric on base heavy atoms only, and sieve set to 5. To 
generate representative structures for the restrained simulations, the average 
structure of the dominate cluster for each trajectory was minimized with full 
restraints. Grid analysis (74) was performed using ptraj and visualized in 
Chimera. Occupancy analysis of water and Na+ was performed using the hbond 




2.4.1 Initial results with unrestrained simulations 
Prior to running the restrained simulations, we performed a set of ~100 
ns unrestrained simulations using the ai5γ_NMR and PL_NMR starting structures 
in order to evaluate the AMBER ff99bsc0 force field; a summary of all of the 
simulations performed is provided in Table 2.1 and a figure highlighting the 
structural and sequence differences is shown in Figure 2.1. These simulations, 
named ai5γ_UR and PL_UR, respectively, were built and equilibrated using the 
same procedure as for the restrained simulations except without any of the 
steps related to the distance, torsion, or RDC restraints. The initial results from 
these simulations led us to begin a more thorough investigation using restrained 
simulations for two reasons. The first is related to the structural compactness 
of the ai5γ_NMR and PL_NMR structures. One of the more striking differences 
between the published ai5γ_NMR and PL_NMR structures is the overall 
structural length, as measured from the top of the tetraloop to the bottom of 
the lower helix. The PL_NMR structures display a compacted global 
conformation that is consistent with and almost as compacted as the X-ray 
structure of ai5γ-D5 (56, 58), whereas the ai5γ_NMR structures are much more 
extended (Figure 2.2). In contrast, when we compared the average structures 
for the unrestrained ai5γ_UR and PL_UR simulations, both sets of structures 
adopted the more compact conformations. Visual inspection of the ai5γ_UR 
trajectories revealed that the end-to-end distance of the structures underwent 
an approximately 15 Å compaction within the first 10 ns of the simulations. 
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This rapid compaction on the MD simulation time scale suggests that the 
extended structure is not compatible with the force field which, as discussed in 
the introduction, is known to fairly reasonably model many RNA structures. The 
PL_UR structures, whose starting structures were already more compact, 
underwent no appreciable compaction during simulation. This likely leads to 
the rather significant difference in plateau RMSD values between the ai5γ_UR 
and PL_UR simulations (Figure 2.4). Note that although the RMSd values 
plateau and appear relatively small, at least in the case of the PL_UR 
structures with RMSd values in the ~3-6 Å range, structural disruption in the 
bulge and loop regions was evident. However, the similarity of the two sets of 
unrestrained simulation structures after MD simulation led us to wonder if 
perhaps the conformation of these two molecules was more similar than the 
conventionally refined structures suggest or if the minimalist gas-phase 
refinement protocol employed previously was insufficient to refine the 
structures. 
The second reason these simulations encouraged us to perform a more 
detailed analysis was related to the localized loop and bulge structural 
features. We found that during both the ai5γ_UR and PL_UR simulations these 
regions experienced significant structural degradation. For instance, at various 
times in the five independent simulations the loop conformation would 
transition to a pathological, yet stable, geometry that often persisted for the 
rest of the trajectory. It was soon clear that accurate modeling of these 
molecules could not be achieved using the MD force field alone, and thus we 
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decided to perform restrained simulations using the original NMR data. While 
the RNA force field parameters have considerably improved (40-45, 75, 76), our 
results suggest the geometries of the refined structures presented in the 
current study are primarily determined by the experimental restraints. The 
explicit solvent environment and updated force field play a secondary yet 
critical role, as the resulting structures appear to be improved compared to 
those obtained using conventional methods. 
2.4.2 Restrained simulations produce conformational  
rearrangements in ai5γ-D5 and PL-D5 
In addition to giving clues about structure compaction, our initial 
investigation of unrestrained simulations led us to hypothesize that the ai5γ-D5 
and PL-D5 structures are more similar than the reported NMR structures 
suggest. To investigate this possibility we ran simulations with distance, angle, 
and residual dipolar coupling (RDC) restraints imposed (i.e., ai5γ_DAR and 
PL_DAR). The resulting trajectories were clustered and a representative 
structure from the most populated cluster for each trajectory was minimized. 
These minimized structures (five total, one for each of the five models of a 
given each simulation type), served together as representative structures for 
each type of simulation (summarized in Figure 2.5 and Table 2.2). A pairwise 
heavy atom RMSD measurement between the ai5γ_DAR and PL_DAR structures, 
which excluded the base atoms for the three differing residues, was much 
lower (3.33 Å) than the corresponding measurement between the ai5γ_NMR 
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and PL_NMR structures (6.03 Å) (RMSD data listed in Table 2.3). A significant 
portion of this decrease was likely due to the structure compaction of 
ai5γ_DAR.  
In addition to a lower interstructure pairwise RMSD with PL_DAR, 
ai5γ_DAR also has a much lower intrastructure pairwise RMSD (2.10 Å) as 
compared to the original ai5γ_NMR structures (4.09 Å). Other than global 
compaction of the structure, the most significant differences between the 
ai5γ_NMR and ai5γ_DAR structures occur in the bulge region. In four out of the 
first five ai5γ_NMR structures, U9 is positioned below residues 24 and 25. For 
ai5γ_DAR, U9 is directly adjacent to A24 and appears to form Watson-Crick 
bonding in three of the five structures. The other two structures show U9 
disengaged from A24 while still maintaining an adjacent stance. In all five 
ai5γ_DAR structures, C25 is pressed against the major groove side of the A8-
U27 base pair, forming a hydrogen bond between A8 H62 and C25 N3 (Figure 
2.6, top). This hydrogen bond seems unlikely due to the high angle between 
the base plane of A8 and C25, and is probably exaggerated by the force field 
which allows such bonding at any angle. The lower position of C25 in the 
ai5γ_DAR structures is likely caused by another interesting feature of the bulge 
region. The kink structure of backbone residues A24 – U27 is even more 
pronounced in the simulation structures than is observed in the NMR structures. 
The otherwise smooth curve of the backbone is disrupted between G26 and 
U27, forming a near right-turn in the helix when viewed from above (Figure 
2.7, left). In the NMR structures, the kink maintains an upward direction 
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throughout the bulge region. In contrast, the ai5γ_DAR kink briefly travels 
downward as it cuts across the major groove and forces C25 into a very low 
position. The orientation of G26 also differs somewhat between the simulation 
and NMR structures. In most of the five ai5γ_NMR structures (models 1-5 from 
the PDB file), the base plane of G26 is close to perpendicular with the vertical 
axis of the lower helix. In contrast, most of the ai5γ_DAR structures have the 
base plane parallel to the vertical axis of the lower helix. 
The differences between the PL_NMR structures and PL_DAR structures 
are not as drastic as those for ai5γ. In contrast to the results for ai5γ, the 
intrastructure pairwise RMSD is higher for PL_DAR (2.56 Å) than for the PL_NMR 
(1.30 Å). One of the most obvious differences between the PL_DAR and PL_NMR 
structures is that during equilibration and relaxation, residue A25 of model 4 
shifted from a partially extruded position in the minor groove to a stacked 
position within the helix. Thus the PL_DAR ensemble has three of five 
structures with A25 stacked, whereas the PL_NMR structures have two of five 
(ignoring structures 6-10 in the published PDB structure file). All five 
representative structures for PL_DAR show U9 participating in a hydrogen bond 
with either A24, A25 or G26. In the two structures with A25 extruded, U9 
interacts with A24. Of the three structures with A25 stacked in the helix, two 
show U9 interacting with A25 and one shows a hydrogen bond between U9 H3 
and G26 N7. During simulations of the former case, U9 shifts back and forth 
between interactions with A24 and A25. In the latter, the U9 H3 - G26 N7 
hydrogen bond is particularly stable throughout the trajectory, leaving A24 and 
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A25 stacked above U9. In all five simulations, these interactions close the 
“hole” described by Seetharaman et al. (56) in reference to the PL_NMR 
structures. Interestingly, for the three structures with A25 in the stacked 
position, G26 no longer “packs into the major groove against G8” (as in all five 
PL_NMR structures), but points away from the major groove with the base 
plane parallel with that of U9. For the two structures with A25 extruded into 
the minor groove, G26 remains oriented towards the major groove.  
2.4.3 Troubleshooting problematic or unusual regions in the  
refined ai5γ-D5 and PL-D5 structures 
On closer inspection of the refined models, some features of both the 
ai5γ_DAR and PL_DAR structures seemed problematic. For ai5γ_DAR, there 
were three distance restraints in the bulge region with consistently large upper 
bound violations during simulation (these restraints connected the following 
atoms: U7 H1’ – A28 H2, G26 H8 – A28 H1’, G26 H8 – U7 H3). Two of these 
involved the atom G26 H8. On closer inspection it seemed possible that these 
two restraints were responsible for the severe kink in the backbone noted by 
the authors of ai5γ_NMR structures as being a very unusual conformation. 
Given the high upper and lower bounds of these restraints, one of the 
corresponding authors (Samuel Butcher, personal communication) suggested to 
us that these restraints were derived from weak NOEs that may be mediated by 
spin diffusion. Even though the U7 H1’ – A28 H2 restraint violation was probably 
a side effect of the other two restraints, we decided to investigate the effect 
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of removing all three problematic restraints. Identical simulations to ai5γ_DAR 
were then run with the three aforementioned restraints removed to generate 
the simulations that are designated as ai5γ_mDAR. 
Additionally, the unrestrained simulations suggested that the positioning 
of the A25 residue in the PL_DAR structures might also be problematic. 
Although the unrestrained simulations are imperfect due to force field 
deficiencies, we never observed A25 extruded into the minor groove during the 
100 ns of unrestrained simulations. As mentioned previously, we also found 
that one fully restrained simulation showed A25 move from the extruded 
position to the stacked position and we therefore considered whether this 
conformation might be preferred. To investigate this, we tested several 
different equilibration and relaxation conditions before choosing a procedure 
for the modified restrained simulations. Many of the conditions resulted in 
either one or two of the three extruded structures transitioning to a stacked 
structure. Critically, in none of these conditions did A25 transition from a 
stacked conformation to an extruded conformation. In one condition, all three 
of the extruded structures transitioned to stacked structures. This condition 
involved three alterations to the PL_DAR simulation procedure: 1) the removal 
of the Watson-Crick base pair restraints, but not the NOESY restraints, between 
residues G8 and C27 (which are not present for A8/U27 in ai5γ_DAR), 2) 
increasing the weight of distance restraints from 20 kcal/mol to 50 kcal/mol as 
well as increasing the G26 χ dihedral restraint from 500 kcal/rad to 1000 
kcal/rad, and 3) heating to 700 K with restraints at 8% strength to allow 
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structural relaxation, followed by a smooth increase of restraint weight to 100% 
strength prior to the production simulation. The rationale for removing the 
Watson-Crick base pair restraints was to allow structural transitions in the 
bulge region that may otherwise be hindered. The changes to the restraint 
weighting were made to ensure the enforcement of distance restraints and 
prevent G26 from flipping to the anti conformation (a frequent problem for 
previous attempts) while the heating period was intended to enhance 
conformational sampling. These simulations were named PL_mDAR. 
2.4.4 Analysis of the bulge and loop regions in  
optimized, restrained simulations 
The removal of the three problematic restraints from the ai5γ restraint 
list makes a significant difference in the bulge region of the ai5γ_mDAR 
structures. First, the intrastructure pairwise RMSD of the ai5γ_mDAR structures 
(1.04 Å) is significantly lower than ai5γ_DAR (2.10 Å) (Table 2.2). The sharp 
kink observed in the bulge of the ai5γ_DAR structures is replaced by a smooth, 
upward trending backbone in the ai5γ_mDAR structures (Figure 2.7, right). 
Rather than being drawn below the major groove face of the A8 – U27 base 
pair, C25 is positioned above A8 – U27 and its base plane is parallel with A8’s in 
the ai5γ_mDAR structures (Figure 2.6, bottom). This positioning puts U9 
directly in between the A24 and C25 bases and during simulation U9 alternates 
hydrogen bonding between A24 and C25. Occasionally, C25 N3 or O2 also form 
a hydrogen bond with the A8 H61, H62 atoms. In contrast to the ai5γ_DAR 
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structures, four of the five ai5γ_mDAR have the base plane of G26 
perpendicular to the helical axis, thus pointing away from the major groove.  
For the PL_mDAR structures, the removal of the A8-U27 Watson-Crick 
base pair restraints and subsequent heating yielded representative structures 
with a lower pairwise RMSD value (1.70 Å) than that of the PL_DAR structures 
(2.56 Å), although not as low as the original NMR structures (1.30 Å). During the 
five PL_mDAR simulations, three different bulge motifs dominate, all of which 
are more packed than the open bulge observed in the original PL_NMR 
structures. In Model 1, the U9H3 - G26N7 hydrogen bond forms (Figure 2.8A). As 
was the case for the same hydrogen bond seen before in model 2 of PL_DAR, 
this structure is quite stable during the simulation. Models 2 and 3 show U9 
interacting with A25, yet U9 never quite reaches A24 (Figure 2.8B). This 
conformation is more dynamic, with U9 oscillating above and below A25. 
Finally, models 4 and 5 show U9 placed between A24 and A25 (Figure 2.8C). In 
these simulations, U9 alternates between interactions with A24, A25 and a 
shared interaction occurs between the two. Interestingly, the positioning of U9 
is correlated with the positioning of G26. In models 1-3, where U9 is interacting 
with A25 or A26 (but not A24), G26 remains partially in the helical stack with 
its base plane perpendicular to the helical axis. However in models 4-5, with 
U9 interacting with A24 and A25, G26 is pushed out of the helix and the base 
plane is parallel to the helical axis. Contrary to the inferences from the 
ai5γ_NMR and PL_NMR structures, the ai5γ_mDAR and PL_mDAR structures are 
quite similar to each other. The average heavy atom pairwise RMSD (excluding 
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the base atoms of differing residues) is much lower (1.95 Å) than the first 
simulation structures (3.33 Å) and the published NMR structures (6.03 Å). In 
addition, the lower helix regions of the re-refined structures are very similar to 
each other and better match the earlier crystal structure (PDB: 1KXK). The 
average heavy atom pairwise RMSD to the crystal for the lower helix is 2.36 Å 
and 1.50 Å for the original NMR structures and 0.81 Å and 1.13 Å for the re-
refined structures (for ai5γ and PL, respectively). The remaining structural 
differences in the bulge are likely related to the accommodation of the larger 
A25 in PL-D5 as opposed to C25 in ai5γ-D5.  
The other noncanonical structure of interest, the GAAA tetraloop, is 
reasonably similar between the NMR structures and among each of the 
restrained simulation structures. These structures are also closer to the earlier 
crystal structure. Whereas the RMSD values for residues 10-23 are 1.64 Å and 
1.79 Å when the original NMR structures are compared to the crystal, the re-
refined structures yield values of 1.37 Å and 0.92 Å (for ai5γ and PL, 
respectively). However, some variation in the backbone torsions are observed, 
such as that of the γ torsion of residue A16, which we attribute to the bsc0 
modifications of the AMBER ff99 parameters which disfavor γ in the trans 
configuration (44). In both the ai5γ_NMR and PL_NMR structures, γ is in the 
trans configuration while in each of the ai5γ_mDAR and PL_mDAR structures 
this torsion is in the gauche+ position. In addition to the backbone differences, 
the base orientations in the tetraloop were compared between the NMR 
structures and the restrained simulation structures. Previous work by Correll 
37 
 
and Swinger identified aspects of the GNRA tetraloop that commonly vary 
between one of two conformations (77). The first of these involves the 
planarity of the “NRA” portion of the tetraloop with respect to the underlying 
base pair of the upper helix (i.e., the planarity of residues 16 – 18 with respect 
to the base pair formed by residues 14 and 19 in the case of D5). When the NRA 
bases are planar with the underlying base pair, the conformation is referred to 
as the “standard orientation.” If the NRA bases depart from planarity, typically 
tilting upward and away from the underlying base pair, the conformation is 
named the “altered orientation.” In both cases, the three NRA bases remain 
stacked together. Visual inspection of both the NMR structures and 
representative structures from our restrained simulations reveal that nearly all 
of the tetraloops adopt the altered orientation. This contrasts with results from 
unrestrained simulations in which the standard orientation seems to be 
favored. 
The second feature of interest identified by Correll and Swinger in GNRA 
tetraloops is the hydrogen bonding network of the first and fourth residues in 
the tetraloop (i.e., G15 and A18 for D5). In the first case (which we name the 
“outward orientation”), G15 N2 forms a bifurcated hydrogen bond between 
both A18 N7 and A18 O2P, while G15 N1 also hydrogen bonds with A18 O2P. In 
the second case (the “inward orientation”), G15 and A18 shift slightly relative 
to the backbone which allows for the same bifurcated hydrogen bond between 
G15 N2 – A18 N7 / A18 O2P as well as a hydrogen bond between G15 N3 and 
A18 N6. Interestingly, the ai5γ_mDAR structures seem to fit the outward 
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orientation, whereas the PL_mDAR structures fit the inward orientation (Figure 
2.9). Both the ai5γ_NMR and PL_NMR structures also appear to adopt the 
inward orientation although the refinement did not seem to capture the fine 
detail of hydrogen bonds that stabilize the structure. For instance, in many of 
the submitted models for both NMR structures, the orientation of G15 N2 does 
not indicate a hydrogen bond is formed with A18 N7, although the atoms are 
close in space. The conformational differences found in the loop regions when 
comparing the ai5γ_mDAR and PL_mDAR structures are surprising given that 
the NMR conditions are similar and the upper helix and tetraloop sequence is 
identical. Slight differences in the restraint data likely lead to the observed 
differences, and as discussed below these conformational differences result in 
slightly different hydration and Na+ binding features. As both loop 
conformations are observed, and each is consistent with experimental data, it 
is not possible to directly ascertain which conformation is preferred and/or if 
the loops interconvert between the two conformations, although likely the two 
conformations are close in energy which suggests population of both. 
2.4.5 Deviations from ideal geometry when using the  
AMBER force field 
One problem which might deter researchers from using the AMBER force 
field is the slight deviations of covalent bond angles from ideal geometries. 
Deviations outside of the expected covalent bond angle range were observed 
for all of our AMBER refined structures as well as other recent structures (78, 
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79) when submitted to the ADIT-NMR (AutoDeposit Input Tool for NMR 
structures: http://deposit.bmrb.wisc.edu/bmrb-adit/) from the RCSB website 
(http://www.rcsb.org). The origin of the deviations results from the use of 
shared, transferable and rather generic atom types for the nucleobases (such 
as CT for all tetrahedral carbons and OS for O2’, O3’, O4’, and O5’) rather than 
specific types for each different atom to more accurately represent nucleoside 
geometry. Although the deviations (on the order of ~5⁰ or less) are outside the 
range observed in experimental databases (80, 81), these deviations are within 
the range of thermal fluctuation and likely have a small impact on the overall 
structural quality due to compensation by the many degrees of freedom in 
large biomolecules. Addressing these deviations will require an overhaul of the 
atom type naming system used by the AMBER force field and is the subject of 
ongoing research. In addition to the deviations observed for covalent bond 
angles, some deviations were also observed in base planarity (on the order of 
0.1 Å rmsd or less), which likely reflect restraint strain on the relatively soft 
improper torsion parameters used in the AMBER force field to maintain 
planarity. 
2.4.6 Comparison of representative ensembles with  
and without RDC restraints 
A comparison between the simulations run with and without RDC 
restraints (DAR and DA, respectively), suggests that the RDCs primarily affect 
the structural compactness of these RNA structures, but not the local 
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conformations. Both the ai5γ_mDAR and PL_mDAR simulations resulted in an 
increase of overall structural length (measured by the distance between A16 P 
and C34 P). The average structure length for ai5γ_mDA and ai5γ_mDAR, taken 
from representative structures, was 47.0 and 54.5 Å, respectively. The increase 
was less dramatic for PL, for which the average structure length was 52.8 and 
53.4 Å for PL_mDA and PL_mDAR, respectively. 
These results are consistent with a recent study by Tolbert et al. (78) of 
a purely A-form RNA double helix, which suggested that a wide range of A-form 
structures are accessible when using only distance and torsion restraints. In 
contrast to what was observed by Tolbert et al., the addition of orientational 
restraints resulted in structural expansion, not contraction. However, the 
differences between the simulations (pure helical RNA vs. noncanonical RNA, 
implicit solvent vs. explicit solvent) preclude further conclusions. 
2.4.7 Solvation and Na+ density during simulation 
In addition to structural information, the publications describing both 
the ai5γ_NMR and PL_NMR solution structures also included data describing 
chemical shift perturbations observed upon titration of D5 RNA with Mg2+. The 
results for ai5γ_NMR, which only tracked 1D proton shift changes, differ 
somewhat from those for PL_NMR, which included more detailed 2D 1H – 13C 
and 1H – 15N chemical shift data. However, these differences could be 
attributed to either a real difference in structure, simply a difference in the 
experimental techniques, or perhaps a combination of these differences. A 
41 
 
detailed examination of Na+ position during the simulation provided a plausible 
explanation for the results observed in the Mg2+ binding experiments. Our 
simulations were performed with monovalent salt due to the lack of good 
parameters for divalent cations, the absence of polarization, and 
conformational sampling limitations. Although the replacement of Mg2+ with 
monovalent salt can destabilize RNA, for small RNAs high monovalent salt 
concentrations are generally a good substitute for physiological Mg2+, and 
typically provide similar structures (82, 83). We studied Na+ and water binding 
during simulation using two techniques. First we generated density grids to 
map positions of highest density over the course of an entire set of simulations. 
Second we probed the occupancy of Na+ and water within a defined radius for 
atoms of interest. 
One of the more significant differences between the results for 
ai5γ_NMR and PL_NMR involved the triad region (A2, G3, and C4). For 
ai5γ_NMR, Sigel et al. found that none of the protons in this region experienced 
a significant perturbation (55). However, Seetharaman et al. reported that N7 
of A2, G30, and G31 were significantly perturbed while N7 of G3 was not (56). 
A comparison of the 3D grid structures for ai5γ_mDAR and PL_mDAR suggest 
that Na+ binding occurs in the tetraloop, bulge, and AGC triad region for both 
structures (Figure 2.10). These data support Seetharaman et al. (56) who 
suggest that probing for perturbations in the N7 atoms of ai5γ-D5 would also 
uncover these results. Furthermore, detailed analysis of Na+ and water density 
near each of the triad region base pairs suggests a possible explanation for why 
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N7 of G3 was not perturbed while N7 of A2, G30 and G31 were perturbed (56). 
In the case of A2 N7 and G30 N7, a high density region of Na+ is positioned 
directly off the N7 atom (Figure 2.11). Occupancy analysis of Na+ within 2.8 Å 
of these two atoms shows that for both ai5γ_mDAR and PL_mDAR they rank 
among the highest in Na+ binding out of all N7 atoms (Figure 2.12). Although 
G31 N7 does not directly bind Na+, a large region of density exists nearby and 
the neighboring O6 atom does bind Na+ at a high occupancy and probably 
contributes to the chemical shift. In the case of residue G3, neither N7 nor O6 
have a high Na+ occupancy, and grid analysis reveals two areas of high water 
density that form a barrier between the Na+ density and residue G3 (Figure 
2.11). 
Another region of interest is the bulge (residues 9, 24, 25, and 26; 
residues 8 and 27 can be included as well). Chemical shift perturbation analysis 
showed that H1’ protons in residues 9 and 25 of ai5γ_NMR were greatly 
affected by Mg2+ titration, whereas only the aromatic carbon and nitrogen 
atoms in residue 24 of PL_NMR were affected. As was observed for the triad 
region, we suspect that carbon and nitrogen chemical shifts in residue 24 would 
have also been perturbed in ai5γ_NMR if they had been monitored. However, 
the shifts of C1’ in residues 9 and 25 of PL_NMR were not affected by Mg2+ as 
was seen for the analogous H1’ for ai5γ_NMR. The simulation data clearly 
account for this difference. Visual inspection of the Na+ density grid for 
ai5γ_mDAR reveals a large, high density region straddling the minor groove 
surface of residues 9, 25 and 27 (Figure 2.13, top). Na+ ions in this region are 
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likely stabilized by the O2 atom of U9, C25, and U27. The positioning of this 
high density region is therefore quite close to the H1’ atoms of these same 
residues and occupancy analysis using a 5 Å cutoff reveals that these H1’ atoms 
are among the nearest to Na+ during simulation (Figure 2.12). In contrast, no 
such high density region is observed for PL_mDAR (Figure 2.13, bottom), and 
the H1’ atoms of U9, A25, and C27 are not near Na+ during the simulation 
(Figure 2.12). It is likely that Na+ binding in this region of PL-D5 is not 
supported for two reasons:  1) the occurrence of adenine at residue 25, rather 
than cytosine in ai5γ-D5, places a hydrogen atom in the binding region, rather 
than an oxygen atom, and therefore does not support metal binding and 2) 
replacement of the A8 – U27 base pair in ai5γ-D5 with the G8 – C27 base for PL-
D5 produces a stronger base pair and does not allow the twisting conformation 
that permits ai5γ-D5’s U27 O2 to interact with a Na+ atom. 
The tetraloop region is the third area of high Na+ binding that is 
identified using grid analysis (Figure 2.14). As noted earlier, the ai5γ_mDAR 
and PL_mDAR loop structures adopt slightly different conformations (both 
adopt the altered orientation of the base planes, but ai5γ_mDAR displays the 
outward orientation of G15 and A18, whereas PL_mDAR adopts the inward 
orientation). A close inspection of the water and Na+ density in the tetraloop 
region reveals that these subtle differences in loop geometry lead to 
differences in ion binding and solvation (Figure 2.15). The solvation patterns 
from simulation closely match those observed in crystal structures by Correll 
and Swinger (77). In the case of ai5γ_mDAR, which adopts the outward 
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orientation, a high density region of water between G15 N3 and A18 N6 likely 
mediates a hydrogen bonding network (Figure 2.15, top). For PL_mDAR, the 
inward orientation of G15 and A18 exclude this region of solvation, but a new 
interaction occurs wherein a water molecule mediates a hydrogen bonding 
network between G15 N1 and A18 O2P (Figure 2.15, bottom). The change in 
base orientation of the tetraloop also results in a shift in the uppermost region 
of Na+ density. For ai5γ_mDAR, the Na+ density is situated between N7 and O6 
of G15 and lies directly below A17O2P, which appears to be coordinating the 
ion (Figure 2.14, top). For PL_mDAR, the Na+ is also located between N7 and 
O6 of G15, but A17 O2P is more distant and any possible coordination 
interaction is intervened by a region of water density (Figure 2.14, bottom). In 
this case, the highly ordered water density that forms around the Na+ density is 
also very similar to that seen in crystal structures, although the ion presence 
was not reported (77).  
The large simulated Na+ density near G15 explains the Mg2+ induced 
chemical shifts for G15 in both ai5γ_NMR (55) and PL_NMR (56) and its location 
in the major groove is consistent with previous NMR work with cobalt(III) 
hexamine (84)). It is less clear why A16 – G19 C1’ shifts are so heavily affected 
in PL_NMR, whereas only the H1’ of G15 is affected for ai5γ_NMR. For A16-A19, 
inspection of the 2D 1H – 13C spectra for H1’ – C1’ reveals that the majority of 
the chemical shift occurs in the carbon dimension (Supplementary Figure 2 in 
Seetharaman et al. (56)) and thus would not be revealed in the ai5γ_NMR 
results where only 1H shifts were measured. However, a significant shift does 
45 
 
occur in the proton dimension of the PL_NMR G19 H1’ – C1’ cross peak, while 
G19 H1’ of ai5γ_NMR is unaffected by Mg2+. Another puzzle is why so many 
atoms of the tetraloop region have large chemical shift perturbations 
(according to the PL_NMR results) when the ion binding appears to be limited 
to the major groove according to the simulation Na+ density grid results. 
Inspection of the medium density solvation shell around the tetraloop region 
reveals that the base atoms are much more exposed to the bulk solvent than 
base atoms in the rest of the RNA molecule (data not shown). We propose that 
this lack of solvent shielding may explain the large Mg2+ induced chemical shift 
perturbations in the tetraloop. 
2.4.8 Simulated annealing with the mDAR restraint sets 
To compare the results of our explicit solvent refinement with 
traditional refinement methods, we performed simulated annealing on the 
completely extended ai5γ and PL RNA, both in vacuo and with Generalized-
Born (GB) implicit solvent, using the mDAR restraint sets. One notable feature 
of in vacuo results is the presence of sharp kinks near the bulge for both the 
ai5γ and PL ensembles. Given that these kinks are not observed in the GB 
ensembles or the explicitly solvated ensembles, these results suggest that in 
regions with sparse distance restraints, such as the bulge, the lack of a 
solvation environment can lead to anomalous conformations. Other than the 
kinked bulge conformation in the in vacuo ensemble, the local conformation of 
both simulated annealing ensembles are very similar to the explicity solvated 
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ensemble. In contrast, comparison of the average structural length of the GB 
ensembles reveals that they are somewhat more extended than the explicit 
ensembles:  for ai5γ_mDAR the average structural lengths are 56.9 and 54.5 Å 
for the GB and explicit, respectively; for PL_mDAR the average lengths are 58.2 
and 53.4 Å. In contrast to what was observed for the explicit ensembles, the 
pairwise RMSD was higher for ai5γ_mDAR GB ensemble (2.54 Å) than that of the 
PL_mDAR GB ensemble (0.74 Å). The reasons for these differences likely lie 
with the representative structure selection method. Whereas the explicit 
solvation representative structures were chosen by their proximity to the 
centroid of the major cluster during a long simulation, the simulated annealing 
structures are simply the lowest energy structures which satisfy restraints from 
a few hundred simulated annealing cycles. It is possible that performing 10,000 
or 20,000 simulated annealing cycles (a similar quantity to the frame count in 
the explicitly solvated simulations) would produce representative structures 
that are in better agreement with the explicit results. However this has yet to 
be investigated. 
2.5 Discussion 
The results presented in this study are immediately relevant to research 
in experimental structure determination and, more specifically, to refinement 
of RNA structure from NMR data. First, for structure refinement projects, we 
find that currently available MD tools with modern simulation protocols, force 
fields, inclusion of water and mobile counterions, and longer molecular 
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dynamics simulations, offer robust environments for probing structural features 
that may not be adequately modeled by older and more conventional structure 
refinement techniques. Our restrained simulations of ai5γ-D5 and PL-D5 
produced a set of refined structures that differed significantly from the 
previously published NMR structures and offer new insights into the similarities 
and differences of these RNA molecules. For instance, the simulation refined 
ai5γ_mDAR structures are much more compact than the original NMR structures 
and more closely resemble both the NMR and simulation structures of PL-D5. 
Moreover, for regions outside the bulge region (which is strongly influenced by 
sequence, packing and tertiary interactions) the re-refined structures better 
match the ai5γ-D5 crystal structure (PDB: 1KXK). We also were able to identify 
and troubleshoot potentially incorrect regional conformations in the 
conventionally refined structures of both molecules. For instance, we 
uncovered three problematic long range distance restraints in the ai5γ-D5 
bulge, which when removed generated a smoother backbone trajectory in the 
bulge region, lower RMSD values, and fewer restraint violations. We also found 
that in three of the five PL-D5 structures, residue 25 was apparently trapped in 
a partially extruded conformation that upon heat annealing converted to the 
stacked conformation having lower RMSD values and fewer restraint violations. 
Noticing the problematic regions required MD simulations orders of magnitude 
longer than were previously and typically applied in order to highlight trapped 
or metastable conformations. Finally, the pairwise RMSD values for the 
simulation ai5γ_mDAR structures are lower than those for PL_mDAR, which is 
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the reverse of what was found using conventional structure refinement. This is 
likely due to the greater flexibility in the bulge region of PL-D5 observed during 
the significantly longer and less-tightly restrained simulations used to re-refine 
the structure. The need to carefully evaluate the choice of NOE and restraint 
assignments (to not only check for misnaming, incorrect assignments, and/or 
potentially anomalous spin diffusion)—coupled with the potential for 
conformational trapping—suggest that automated NMR refinement of RNA 
structures remains a challenge. Our results suggest that the refinement of RNA 
structures requires a careful balance between the strength of the experimental 
restraints and the influence of the force field, and perhaps most importantly, 
the resulting structures require careful validation and assessment. 
The publication of a self-spliced group IIc intron crystal structure (59) 
reveals that the D5 bulge adopts a different conformation in the context of the 
entire intron than in isolation. Therefore, while our refinement of the original 
NMR structures provides new insight into the isolated RNA hairpins, the 
functional relevance of these structures in the context of the intact intron 
remains unclear. However, the results clearly suggest that the bulge 
conformation is sensitive to the surroundings and sequence, and that the re-
refinement leads to structures that are more consistent with the available 
crystal structures. Our simulations also suggest that these hairpin structures, 
which differ at only three positions, are much more similar than the older 
conventional refinement techniques indicated. These results also improve our 
understanding of how differences in primary sequence affect 3D structure, and 
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provide insight into conformational flexibility, solvation, and ion binding. The 
isolated D5 bulge apparently samples a range of conformations, while tertiary 
interactions in the context of the entire intron select and stabilize a flipped 
out conformation necessary to assemble a catalytically active intron (59). MD 
simulations with explicit solvent and updated force fields can potentially 
uncover minor conformers that nevertheless have functional relevance. The 
flipped out conformation need not be the lowest energy structure observed by 
NMR, merely accessible with sufficient frequency to be captured by tertiary 
contacts in the intron. Accurate “ground state” structures determined from 
NMR data and explicit solvation MD provide a starting point from which to 
investigate the dynamical behavior of RNA. The methods employed in this 
paper should also aid researchers who use structural databases to further 
refine their models. 
Remaining unanswered questions relate to potential disorder and/or 
dynamics in the bulge and loop regions. MD simulations without experimentally 
derived restraints are unable to maintain the expected structure; given this, 
movement away from the experimental structure does not represent true 
dynamics, but suggests deficiencies in the force field. Researchers may be 
interested in the minimal set of restraints required to maintain experimentally 
valid structures. We propose that the minimal restraint requirements for 
maintaining accurate structure using the AMBER force field would include as 
many distance restraints in noncanonical regions as possible and orientational 
restraints such as RDCs to maintain proper structural compaction. Although 
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structures consistent with the experimental data can be maintained via the 
application of restraints, such restraints will tend to inhibit conformational 
transitions and dynamics. Given this, it is unclear if the representative 
structures found in re-refinement completely represent the ensemble of 
frequently accessed conformations or simply represent the lowest energy 
structures without a proper depiction of the true disorder or dynamics sampled 
at room temperature. For instance, depending on the choice of experimental 
restraints, two GAAA tetraloop conformations, each with distinct solvation and 
ion binding properties were observed. Both are consistent with experiment. 
However, as exchange was not observed between “outward” and “inward” 
structures during the re-refinement, speculation on the relative populations or 
conformational dynamics is not possible. On the other hand, given that both 
are observed experimentally and are likely nearly isoenergetic, it is likely that 
both are populated and in dynamic equilibrium. To further resolve these 
questions through simulation will require improvements in the underlying 
nucleic acid force fields. 
The AMBER force field is continually being developed and refined to 
produce improved simulation results. Generally these improvements are 
evaluated in the context of unrestrained simulations. However, evaluating 
force field performance is difficult given the huge diversity in RNA structure. 
Our unpublished work suggests that canonical A-form RNA is relatively stable in 
unrestrained simulations for long periods of time. In contrast, noncanonical 
regions frequently populate conformations which are not observed in 
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experimental structures suggesting a force field problem. One notable RNA 
motif for which this occurs is the UUCG tetraloop. Progress towards improving 
RNA torsional parameters is underway, including recent force field 










Figure 2.1. Comparison of the secondary and 3D structures for domain 5 of 
the Group II Intron from yeast ai5γ (ai5γ_NMR, PDB code 1R2P, left) and 
Pylaiella littoralis (PL_NMR, PDB code 2F88, right). The structural elements 
are indicated by color: tetraloop (pink), upper helix (blue), bulge (green), 







Figure 2.2. Molecular graphics representations of the heavy atoms of the 
previously and newly refined 34-residue portions of the domain 5 group II 
intron structures highlighting the differences in the bulge region. Shown are, 
from left to right, the earlier yeast ai5γ (55) (ai5γ-D5, PDB: 1R2P), the 
Pylaiella littoralis (56) (PL-D5, PDB: 2F88), a portion of the earlier crystal 
structure of ai5γ-D5 (58), the first structure of the mDAR/DxAR (i.e., refined 
including distance and angle restraints, residual dipolar coupling restraints, 
and removal of a few bad NOE restraints due to spin diffusion as per the 
main text) re-refinement of ai5γ, and the first structure of the mDAR/DAR-
heat (i.e. refined with all of the restraint information and an additional 
heating step for better sampling as per the main text) re-refinement of PL-




































































































































Table 2.1. Simulation details and nomenclature for refinements in this work. 
 
Name No. of 
Simulations 
   Simulation Notes Time† 
ai5γ_UR 5 Unrestrained simulation 111 ns 
ai5γ_DA 5 Distance and angle restraints 
enforced 
20 ns 
ai5γ_DAR 5 Distance, angle, and RDC restraints 
enforced 
8 ns* 
ai5γ_mDA 5 Modified distance and angle 
restraints enforced 
20 ns 
ai5γ_mDAR 5 Modified distance, angle and RDC 
restraints enforced 
8 ns* 
PL_UR 5 Unrestrained simulation 92 ns 
PL_DA 5 Modified distance and angle 
restraints enforced 
20 ns 
PL_DAR 5 Distance, angle, and RDC restraints 
enforced 
8 ns* 
PL_mDA 5 Modified distance and angle 
restraints enforced;  additional 
heating step 
23 ns 




†The time listed is for the minimum trajectory length of the five models. 








Figure 2.4. RMSD plot for the five unrestrained (UR) simulations of each PDB 
structure. PDB 1R2P or ai5γ_UR (top) and PDB 2F88 or PL_UR (bottom) 
simulations. RMSD values were calculated by fit to the initial structure. 
Although the RMSD values plateau, the RMSd values are relatively high 






Figure 2.5. Representative structures for A) ai5γ_NMR, B) ai5γ_DAR, C) 
ai5γ_mDAR, D) PL_NMR, E) PL_DAR, and F) PL_mDAR. The “NMR” suffix 
denotes the original ensemble from earlier refinement (ai5γ_NMR is PDB: 
1R2P, PL_NMR is PDB: 2F88). “DAR” refers to the representative structure 
from the dominant ensemble sampled during the five independent explicit 
water MD simulations with distance, torsion angle, and residual dipolar 
coupling restraints enforced. “mDAR” is identical to “DAR” except with 
small modifications to the restraint list or the equilibration protocol as 







Table 2.2. Structural statistics for ai5γ-D5 and PL-D5 representative 
structures. 
 
                       ai5γ-D5 PL-D5 
 NMR DAR mDAR NMR DAR mDAR 
No. of Structures 5 5 5 5 5 5 
No. of Distance Restraints 595 595 592 549 549 543 
No. of Dihedral Restraints 238 238 238 247 247 247 
No. of RDC Restraints 24 24 24 37 37 37 
Avg. RMSd of Distance (Å) 0.021 0.020 0.016 0.019 0.028 0.013 
Avg. RMSd of Dihedral (°) 0.482 0.378 0.365 0.703 0.152 0.239 
Avg. RMSd of RDC (Hz) 1.897 2.939 3.067 3.115 4.324 4.390 
No. Distance Viol. >0.2 Å 4 5 0 2 13 0 
No. Angle Viol >5.0 ° 5 4 3 7 0 1 
        
Overall Heavy Atom RMSD             
 
Avg. RMSd from mean 
2.58±0.84 1.41±0.29 0.66±0.32 0.83±0.12 1.69±0.45 1.14±0.28 
Avg. RMSd pairwise 4.09±1.20 2.10±0.87 1.04±0.46 1.30±0.24 2.56±1.04 1.70±0.76 
 
Note: The corresponding structures are depicted in Figure 2.5. Definitions of 





Table 2.3. Pairwise RMSD measurements. 
 
 
  Comparison Pairwise RMSD 
ai5γ_NMR vs. PL_NMR 6.03 ± 1.00 
ai5γ_NMR vs. ai5γ_DAR 7.18 ± 1.52 
ai5γ_NMR vs. ai5γ_mDAR 5.61 ± 1.22 
ai5γ_NMR vs. PL_DAR 6.55 ± 1.69 
ai5γ_NMR vs PL_mDAR 6.18 ± 1.34 
   
PL_NMR vs. ai5γ_DAR 4.29 ± 0.52 
PL_NMR vs. ai5γ_mDAR 2.71 ± 0.15 
PL_NMR vs. PL_DAR 2.67 ± 0.63 
PL_NMR vs. PL_mDAR 2.21 ± 0.40 
   
ai5γ_DAR vs. PL_DAR 3.33 ± 0.61 
ai5γ_DAR vs. PL_mDAR 3.23 ± 0.70 
ai5γ_mDAR vs. PL_DAR 2.33 ± 0.82 
ai5γ_mDAR vs. PL_mDAR 1.95 ± 0.40 
   
ai5γ_DAR vs. ai5γ_mDAR 3.13 ± 0.66 
PL_DAR vs. PL_mDAR 2.00 ± 0.88 
 







Figure 2.6. The bulge structures from the re-refined NMR structures: 








Figure 2.7. Side and top views of ai5γ_DAR (left) and ai5γ_mDAR (right). 
The top view has been truncated to focus on the bulge region. The backbone 














Figure 2.9. A comparison of the outward orientation (green) and inward 










Figure 2.10. Stereo views of the Na+ density grid maps for ai5γ_mDAR (top) 
and PL_mDAR (bottom). The isosurface grid density was chosen to show 










Figure 2.11. Comparison of water and Na+ densities in the major groove of 





















































































































































Figure 2.13. Stereo view of the Na+ density grid in the bulge region of 








Figure 2.14. Stereo view of the Na+ density grid in the loop region of 








Figure 2.15. Water and Na+ density grid in the region near the non-Watson-
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3.1 Chapter Notes 
 This research was designed by Niel M. Henriksen and Thomas E. 
Cheatham, III. The simulations, free energy analysis, and docking of the RESP 
charged inhibitors were performed by N.M. Henriksen. Hamed S. Hayatshahi 
performed docking with the AM1-BCC charged inhibitors. The manuscript was 
written by N.M. Henriksen. The manuscript was revised by N.M. Henriksen, H.S. 
Hayatshahi, Darrell R. Davis, and T.E. Cheatham, III. 
3.2 Introduction 
RNA performs a vast array of functions in biological systems, including 
genetic encoding, regulation, and catalysis (1-3), and yet very few drugs exist 
which target RNA (4). This may be the result of many factors, including the 
relatively recent discovery of RNA’s many biological roles and the difficulty in 
preventing RNA degradation during experiments, particularly by ribonucleases 
(5, 6). Likewise, computational investigations of RNA-ligand binding are 
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comparatively rare (PubMed search of “protein binding simulations” as of 
December 2012 yields 6387 results, “rna binding simulations” yields 407 
results) (7, 8). In order to address this scarcity, this study reports the results of 
molecular dynamics (MD) simulations on a specific RNA-ligand system and aims 
to provide a more reliable foundation for future studies involving highly 
charged complexes, such as those described here. 
The target of this research is the domain IIa RNA sequence from the 
hepatitis C virus internal ribosome entry site (HCV IRES) (9). Experimental 
structures exist for both the unbound (or free) structure (10, 11) and also of 
the RNA in complex with 2-aminobenzimidazole inhibitors (12, 13). This RNA-
inhibitor complex is an attractive structure to study because it involves a 
relatively short RNA sequence bound to a drug-like molecule. This contrasts 
with typical structures that are often larger and more complex, such as RNA or 
ribo-protein molecules in complex with aminoglycosides (14, 15). Moreover, 
distinct structural differences between the free and bound conformations are 
observed, and this is most notably characterized by the loss of a key bend in 
the RNA upon ligand binding that explains the inhibition mechanism (16). 
Biologically, the structure is of interest due to both the high degree of 
sequence conservation in IRES elements and its importance in HCV genome 
translation and viral replication (17). Rather than using the 5’ cap-dependent 
mechanism to initiate translation at the ribosome, as is typical in eukaryotes, 
the HCV IRES element is responsible for recruiting the 40S ribosomal subunits. 
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Thus, development of inhibitors of the IRES machinery could be useful tool in 
treating hepatitis C infections. 
The 2-aminobenzimidazole inhibitors used in the experimental structures 
(J4 and J5) were discovered by Isis Pharmaceuticals, Inc. along with several 
others (Figure 3.1) using a high throughput mass-spectrometry assay and these 
inhibitors were found to reduce HCV RNA levels in a viral replication assay (18). 
As part of their exploration of structure-activity relationships, a number of 
different derivatives were synthesized and binding constants estimated (Table 
3.1). This provides a series of related inhibitors, studied by the same laboratory 
with equivalent and comparable experiments, which can be investigated in 
simulation to assess the biomolecular simulation protocols. Unfortunately, for 
the desired assessment, there are several drawbacks to the experimental data 
for these inhibitors, specifically: 1) the protonation state of the inhibitor upon 
binding is unknown, 2) several inhibitors were synthesized as racemic mixtures 
of enantiomers or diastereomers and the experimental binding data published 
do not distinguish the results based on the stereochemistry, and 3) the errors in 
the binding measurements were not reported. Not all of these issues preclude 
the assessment. For example, the protonation states can be estimated with 
reasonable accuracy using various pKa estimation software (see METHODS) and 
these calculations suggest that the inhibitors are all fully protonated in solution 
at physiological pH as depicted in Figure 3.1. With regard to stereochemistry, it 
is very easy to perform separate calculations on each of the enantiomers and 
diastereomers, and, when necessary, report the mean value for comparison 
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with experimental data. The lack of error analysis in the experimental binding 
constant data, however, does suggest the use of caution when making certain 
conclusions based on comparison of the experimental and computational 
results. 
The experimental structures of the RNA-inhibitor complex, two derived 
from NMR data (12) and one from X-ray crystallography (13), exhibit distinctly 
different binding modes. These differences cannot easily be attributed to the 
identity of the two different inhibitors used in the separate investigations as 
they only differ by a single -CH2- group (see J4 and J5 in Figure 3.1). These 
differences also cannot be attributed to the slight change in RNA sequence in 
the NMR versus crystal, as the sequence changes are only found at the ends of 
the molecule as shown and discussed in Figure 3.2A. Rather the differences 
must lie in the experimental method used to gather data, the structure 
refinement procedures, and/or potential crystal packing artifacts. The NMR 
structure can be described as an open conformation with stacking contacts 
formed below the inhibitor, a single phosphate-dimethylamino interaction, and 
a single base pair-dimethylamino interaction (Figures 3.2B, 3.3A). Lateral 
contacts between the benzimidazole ring and RNA are not observed. In 
contrast, the crystal structure is more compact, stacking interactions are 
formed both above and below the inhibitor, both dimethylamino groups 
interact with the RNA phosphate backbone, and two critical hydrogen bonds 
are formed between the benzimidazole ring and the residue G33 in the binding 
site (Figures 3.2C, 3.3B, 3.4).  
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In addition to the differences in the conformations of the NMR and 
crystal structures, there are potentially conflicting reports regarding the cation 
requirements necessary for the formation of the inhibitor bound complex. 
Magnesium is observed at core positions in both the unbound and bound crystal 
structures (11, 13). It is also found that removal of magnesium from the FRET 
binding assay of the crystal structure yields a ~30 fold decrease in binding 
affinity (13). Although these findings are consistent with the well-known 
relationships between RNA structure and cation binding (19, 20), they should 
not be interpreted to suggest that specifically bound magnesium exclusively 
performs the stabilization role (21). A variety of RNA tertiary structures are 
known to form in moderate levels of monovalent salt (22) and magnesium is 
known to compete with monovalent cations in stabilizing RNA (23). In the case 
of the HCV IRES domain IIa RNA, although the addition of magnesium stabilizes 
the unbound solution structure (10), no changes were observed in the NMR 
spectra of the bound complex upon addition of magnesium to a solution with a 
relatively high monovalent salt concentration (12). Additionally, a fluorescence 
binding assay of the NMR sequence conducted in 0.15 M KCl and 0.15 M NaCl 
using the J4 inhibitor (Figure 3.1) yielded a dissociation constant in the 
equivalent range (2.4 μM) (12) as the value determined by FRET assay for the 
crystal sequence binding to the J5 inhibitor in 2 mM Mg2+ (EC50 = 3.4 μM) (13).  
To address the discrepancies in the experimental data regarding inhibitor 
binding to the HCV IRES domain IIa, we have performed a variety of MD 
simulations using the reported NMR and crystal experimental conformations. 
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Stable MD simulations are observed for the crystal conformations, and we also 
observed the partial transition of an “unstable” NMR conformation to a more 
crystal-like conformation. Stable simulations are a necessary first step for 
future modeling studies of RNA-ligand interaction and computer-aided drug 
design, and stable MD simulations are not a guaranteed outcome using even the 
latest RNA force fields (24, 25). Indeed, recent force field improvements are 
required to correct pathological simulation behavior of RNA (26-30) and further 
improvements are still likely necessary (unpublished data). In the case of the 
crystal structure simulations on the 200 ns time scale, however, the AMBER 
ff12SB force field (which includes the parmbsc0 (26) α/γ backbone and RNA 
ΧOL (28) modifications to the ff99 (31-33) force field) appears to be sufficiently 
accurate. Next, to test whether small changes in the inhibitor lead to 
discernible changes in the binding mode, we investigate the binding of six 
related inhibitors (yielding twelve stereochemically distinct compounds). We 
also examine whether magnesium ions are essential for stable simulations of 
the crystal conformation. Finally, in anticipation of further inhibitor 
development using computational models, we investigate methods for 
determining accurate binding energies, entropic penalties, and ligand docking 
procedures. We also investigate whether a novel drug scaffold is capable of 




3.3.1 Ligand parameterization 
All inhibitors in this study were protonated at the dimethylamino and 
benzimidazole positions as indicated in Figure 3.1. The fully protonated state 
at pH 7.0 is consistent with pKa estimates by two different pKa prediction 
programs, SPARC (34) and Marvin Sketch (35). Charge derivation was performed 
in a very careful manner due to the highly charged nature of the inhibitors:  1) 
A hand-built inhibitor model was geometry optimized at the QM HF/6-31G* 
level consistent with the AMBER ff10 and ff12SB force fields followed by 
restrained electrostatic potential (RESP) (36) charge fitting to determine initial 
atomic charges; 2) 50 ns of implicit solvent generalized-Born (GB) MD, using 
Hawking, Cramer, and Truhlar model (37), was performed at 400K to sample 
relevant inhibitor conformations, and the resulting trajectory was clustered 
(38) using the “averagelinkage” algorithm into twenty clusters using AMBER’s 
Ptraj program; 3) the representative structure from clusters whose occupancy 
was greater than 2% were then geometry optimized at the QM HF/6-31G* level; 
and 4) optimized structures whose energy was within ~0.5 kcal/mol of the 
minimum energy structure were used in a multiconformation, multi-orientation 
RESP fit using the RED program (39) to generate the final charges used in this 
study. Enantiomers were fit simultaneously to ensure identical charges. Bonds, 
angles, torsions, improper torsions and Lennard-Jones parameters were 
assigned from the general AMBER Force Field (GAFF) using the Antechamber 
and Parmchk programs (40-42). Some torsions and improper torsion parameters 
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were modified because the default parameters did not maintain planarity at 
the C2 position of the 2-aminobenzimidazole ring. MOL2 files with GAFF atom 
types and charges, as well as “frcmod” files with the modified torsion 
parameters are provided in the Supplementary Information. All quantum 
mechanical calculations were performed using Gaussian09 (43) and all MD 
simulations were performed using AMBER12 (44). 
In addition to the more detailed approach to generate high quality atom 
charges discussed above, we were interested in the performance of more 
approximate charge parameterization methods. To test this, we performed 
molecular docking studies (discussed below) using both the RESP charges from 
the above procedure and AM1-BCC (45, 46) charges produced by AMBER’s 
Antechamber program. In the latter case, charges were determined separately 
for each inhibitor conformation studied. 
3.3.2 Initial RNA–inhibitor conformations 
Experimentally determined atomic resolution structures exist for both 
the J4R and J4S inhibitors (as NMR structures) and also for the J5R inhibitor (as 
a crystal structure). To facilitate comparisons between the MD simulations, the 
crystal structure duplex was converted into a hairpin of identical sequence to 
the NMR structure. To accomplish this, the 3’ dangling bases were removed, 
the C-G basepair at the base of the lower stem was converted to a G-C 
basepair, and a UUCG tetraloop was added to the opposite stem (Figure 3.2A). 
In order to generate a diverse set of binding conformations for the inhibitors in 
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Figure 3.1, the twenty representative conformations of each inhibitor 
identified by clustering during the charge derivation procedure were RMS fit to 
the benzimidazole core atoms of the experimental structure, either NMR or 
crystal. For the NMR structure, the first model from the PDB 2KU0 (12) 
ensemble was used as the reference structure. This procedure resulted in the 
generation of twenty “NMR-like” RNA-inhibitor conformations and twenty 
“crystal-like” RNA-inhibitor conformations for each of the twelve 
stereochemically distinct inhibitors. The selection of these conformations as 
initial structures for the various simulation sets in this work is described in the 
following section. Simulations which included magnesium used the exact 
coordinates from the crystal structure for the J5R inhibitor, magnesium, and 
RNA with the necessary sequence modifications included so as to match the 
NMR sequence. In the case of the novel ligands, a single inhibitor conformation 
was chosen and RMS fit to the benzimidazole core atoms in the crystal 
experimental structure. 
3.3.3 Simulation sets 
As described in Table 3.2, several sets of simulations were performed. 
For RNA-inhibitor studies, two strategies were employed: single long 
simulations and multiple short simulations. For the single long simulation sets 
(NMR1 and CRY1), a single initial structure was selected from the twenty initial 
conformations for each of the twelve inhibitors based on the minimum GB 
energy of the complex. For the multiple simulation set (CRY2), all twenty 
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initial conformations were used. In a few cases, bad initial conformations were 
replaced with good conformations due to severe atom overlap. 
3.3.4 Building solvated models 
The domain IIa RNA was parameterized using AMBER’s ff12SB force field. 
The initial RNA-inhibitor conformations were first minimized for 2500 cycles 
using the steepest descent algorithm in implicit GB solvent and the resulting 
geometries were solvated. All simulations described in Table 3.2 were 
performed in TIP3P (47) water with net-neutralizing potassium ions and an 
additional ~200 mM KCl as parameterized by Joung and Cheatham (48). The 
number of waters added was chosen to yield a periodic truncated octahedron 
with an approximately 12 Å minimum water shell between the solute and the 
box edge. In order to facilitate energetic comparison between inhibitors, the 
number of solvent atoms for systems in each simulation set were made to be 
identical using an in-house Perl script coupled to AMBER’s LEaP program. In the 
case of the J1 inhibitor, which has +2 net charge rather than +3, direct 
energetic comparisons with the other inhibitors was not performed. Following 
solvation, the monovalent ion positions were randomized with AMBER’s Ptraj 
program using the “randomizeions” command to remove bias from the initial 
ion placement. In the case of the MG simulation (Table 3.2), the 
crystallographic magnesium ions and water molecules were included using 




3.3.5 Molecular dynamics simulations 
All solvated simulations used a similar minimization, heating, and 
equilibration procedure: 1) The entire system was minimized for 1000 steps 
using the steepest descent algorithm followed by 1000 steps of conjugate 
gradient minimization while 25 kcal/mol-Å2 positional restraints were enforced 
on the RNA and inhibitor benzimidazole core atoms, 2) the system was heated, 
with 25 kcal/mol-Å2 positional restraints on the RNA and benzimidazole core 
atoms, from 10 to 150 K  at constant volume with the Langevin thermostat over 
the course of 100 ps, 3)  further heating and initial equilibration was performed 
from 150 to 298 K using constant pressure and the Langevin thermostat with 5 
kcal/mol-Å2 positional restraints on all solute atoms over the course of 100 ps, 
and 4) final equilibration at 298 K was performed for 2 ns using constant 
pressure and Langevin thermostat with 0.5 kcal/mol-Å2 positional restraints on 
the RNA and benzimidazole core atoms. Production simulations were performed 
at 298 K at constant pressure using the weak-coupling algorithm for the 
thermostat and barostat (50). The pressure relaxation times were 1 ps for the 
initial equilibration step, 5 ps for the final equilibration step, and 10 ps for 
production. For heating and both equilibration steps a collision frequency of 2 
ps-1 was used for the Langevin thermostat. For production, the time constant of 
heat bath coupling was 10 ps using the weak-coupling algorithm. For all 
heating, equilibration, and production steps, the time step was 2 fs, the direct 
space sum used a cutoff of 8.0 Å, and SHAKE was applied to all bonds involving 
a hydrogen atom (51). The default particle mesh Ewald (52) settings were used 
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to determine long-range charge interactions (which correspond to an ~1 Å grid 
spacing and a 10-6 direct space tolerance). Coordinates were recorded every 
picosecond during production simulations. All solvated simulations, with the 
exception of one performed with residual dipolar coupling (RDC) restraints, 
were performed using either the CPU or GPU version of the PMEMD program in 
AMBER12 (44). A single simulation using the crystal conformation was 
performed using AMBER’s Sander program with the NMR RDC restraints enforced 
(the use of RDC restraints is not yet implemented in the faster PMEMD 
program). A short minimization was performed on the equilibrated, solvated 
structure to best fit the RDC alignment tensor. The relative weighting for the 
alignment restraint was chosen to be 0.08 kcal/Hz2, which represents an 
empirical determination of the largest value that does not produce simulation 
instability (e.g., integration errors).  
3.3.6 Energy analysis 
MM-GBSA and MM-PBSA are well-known postprocessing techniques for 
computing binding energies from simulation trajectories (53-55). In this work, 
MM-GBSA and MM-PBSA analyses were performed with the MMPBSA.py program 
in AMBER12 using the single trajectory approach. For MM-GBSA, the Hawkins, 
Cramer, and Truhlar GB model (37) was used for implicit solvation with 200 mM 
salt concentration approximated using Debye-Huckel screening. For MM-PBSA, 
the following options were used: a level-set based dielectric model, a two-term 
nonpolar solvation free energy term based on a cavity and dispersion 
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calculation (56, 57), 200 mM ionic strength, 1.4 Å solvent probe, 0.25 Å grid 
spacing, and the ratio between the longest grid dimension and the solute set to 
6.0. Radii for inhibitors were chosen from a set of optimized radii to best 
match the atom types present (56). For MM-GBSA, all frames from the 
trajectory were used, but for MM-PBSA only every 100th frame was used for 
computational efficiency reasons.  
In addition to the MM-GBSA/MM-PBSA framework of energy analysis, we 
also calculated relative binding energies which included explicit solvent effects 
by subtracting the solvated inhibitor average potential energies (from 
simulations of the free ligands in explicit solvent, LIG) from the solvated RNA-
inhibitor average potential energies (CRY1 and CRY2). These binding energies, 
which are formally an estimate of the binding enthalpy (the kinetic energy and 
pressure/volume contribution is assumed to be negligible), do not include 
additional entropy estimates. The inhibitor J1 was excluded from these 
calculations due to its +2 charge which complicates direct comparison due to 
differences in the number of counterions.  
Besides binding energy calculations, we also performed two types of 
entropy analysis. In both cases, only the inhibitor entropy was considered and 
energy changes were computed by subtracting the free inhibitor entropy from 
the complexed inhibitor entropy (CRY1 minus LIG). The first method, quasi-
harmonic analysis (58), was computed using AMBER’s Ptraj program. The 
second method, first-order configurational entropy analysis based on 
bond/angle/torsion probability distribution functions, was computed using the 
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ACCENT program developed by Gilson and co-workers (59). Both methods 
ignore rotational and translational contributions to entropy. Due to the 
accumulative nature of these values, error bars are not given for the entropy 
estimates which were estimated over equivalent time windows. 
Finally, inhibitor solvation energies were estimated by subtracting gas 
phase average potential energies from either GB implicit solvation energies or 
from potential energies of explicitly solvated trajectories. Although one could 
compute the gas phase energies from solvated trajectories by stripping the 
solvent, we performed 100 ns gas phase simulations for each of the twelve 
inhibitors represented in Figure 3.1 in order to ensure independence of these 
values. 
3.3.7 Error analysis 
Two approaches were used to estimate error depending on the 
simulation set. For the single long simulation sets, a previously described re-
blocking procedure was used (60). Briefly, a data set plotting the standard 
error of the mean (SEM) versus increasing block size is computed. Given 
sufficient sampling, the plot will plateau at a value that corresponds with the 
SEM. A trend line fit can be used to predict this value. However, due to 
assumptions about the correlation in the data, the result can be inaccurate. To 
be conservative, we use the maximum value observed in the plot. An example 
of this error analysis is given in Figure 3.5. For the multiple short simulation set 
(CRY2), we can consider the average value from each of the twenty separate 
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simulations as being independent, uncorrelated data points and compute the 
SEM in the traditional way by dividing the sample standard deviation by the 
square root of the number of data points (i.e., number of simulations). Error 
combining rules were as follows: when computing the difference of two mean 
values, the errors were added; when computing the average of two or more 
mean values, the errors were averaged. 
3.3.8 Grid analysis 
The regions of highest magnesium ion occupancy were determined using 
the “grid” command in AMBER’s Ptraj program (61). The simulation trajectory 
frames were centered, imaged, and RMS fit using the heavy atoms of residues 
5, 11, 33, and 34 that form the binding region. Occupancy was determined by a 
three dimensional histogram approach using a 75 x 75 x 75 Å box with 0.5 x 0.5 
x 0.5 Å resolution. The results are visualized on the average RNA-inhibitor 
structure from the simulation using UCSF Chimera package (62). To choose the 
density surface contour level to be displayed, the contour level was increased 
until magnesium occupancy in the bulk solvent region was no longer observed, 
thus suggesting stable binding locations. 
3.3.9 Docking 
Docking was performed on the crystal receptor structure (modified to 
match the full NMR sequence, Figure 3.2A) using Dock 6.5 (7). The top and 
bottom helical portions of the receptor were excluded from consideration as 
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they are known to not contain the binding site. This exclusion did not 
inappropriately limit docking poses to the known binding cavity since the entire 
backside region of the receptor was explored for docking. In order to include 
various ring pucker conformations in some of the inhibitors, for which Dock 6.5 
is not able to search automatically, all of the inhibitor conformational clusters 
whose occupancy was greater than 2% (identified during the charge derivation 
procedure) were used as initial seed structures for docking. Two schemes were 
used to assign charges to the inhibitor for use during docking. The first scheme 
simply used the RESP charges that were derived for use in MD simulations. In 
the second scheme, which resembles a more typical docking procedure, 
charges were derived for each inhibitor conformation using the semi-empirical 
AM1-BCC charge model which can be accessed through the AMBER’s 
antechamber program. The default grid-based method in Dock 6.5 was assigned 
as the primary scoring function. 
3.4 Results 
3.4.1 MD simulations 
The NMR1 and CRY1 simulation sets (Table 3.2) were intended to 
evaluate the simulation stability of the two available experimental 
conformations in the context of twelve related inhibitors over a fairly long 
timescale (200+ ns). Visual inspection of the simulation trajectories reveals a 
stark contrast in the stability of the binding region. A quantitative measure of 
this difference is shown in Figure 3.6, where the binding region RMSD is plotted 
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versus simulation time using the initial conformation of the each production 
simulation as reference. For all twelve simulations in the CRY1 simulation set 
(shown in black) the RMSD value is low and very steady. The small fluctuations 
arise from inhibitor ring transitions and conformational searching by the 
dimethylamino groups. Throughout the CRY1 simulations all of the critical 
contacts depicted in Figure 3.4 are maintained in each simulation. In contrast 
to the CRY1 results, the NMR1 RMSD results (shown in red) reveal a high degree 
of fluctuation and departure from the initial structure. A variety of RNA-
inhibitor poses are adopted during the twelve NMR1 simulations and do not 
point to a consensus alternative to the original NMR pose. Much of the 
structural instability is due to conformational transitions in the bulge residues 
6-10. To visualize the structural difference between the NMR1 and CRY1 
simulation sets, the final frame of each simulation was overlaid to produce an 
ensemble (Figure 3.7). Due to unfolding of the bulge residues, many of the 
NMR1 conformations do not retain the linear RNA orientation known to inhibit 
viral replication, but rather adopt the “L-shaped” conformation similar to the 
unbound structure (Figure 3.7A). Additionally, the inhibitor poses are smeared 
into a variety of orientations (Figure 3.7C). In contrast, the CRY1 simulations 
maintain the linear orientation and produce a rather tight ensemble of 
structures and inhibitor poses (Figure 3.7B,D).  
One of the NMR1 simulations, that with the J5S inhibitor, is notable 
because it partially converts to the conformation of the crystal structure. All of 
the critical contacts in Figure 3.4 are observed, including the hydrogen bonds 
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between the inhibitor and G33 and the contacts between the dimethylamino 
groups and the phosphate backbone (Figure 3.8A). These distances are similar 
to those observed in the CRY1 simulation set (Figure 3.8B). The only interaction 
that is not formed is the base triple interaction between residue A6 and the 
Hoogsteen edge of A32, which forms a “roof” above the inhibitor. After 232 ns 
of simulation, the conformation of residues 7-9 continues to restrain the 
flexibility of A6 in such a way as to prevent the full formation of the base 
triple, although A6 and A32 are near enough to form direct contacts. Other 
simulations in the NMR1 set also partially adopt the crystal-like binding mode, 
usually by forming the hydrogen bonds between the inhibitor and G33, but 
none are as stable as the aforementioned simulation with J5S. Further 
research, likely involving enhanced sampling, is necessary to determine 
whether a complete transition is accessible on a reasonable timescale.  
In addition to using long simulations, we also investigated if using many 
shorter simulations with diverse initial inhibitor conformations could produce 
comparable data. Due to the instability of the NMR conformation in simulation, 
we only discuss this approach for the crystal conformation which we term the 
CRY2 simulation set. Most comparisons are made in the energetic analysis 
portion of the results, but we also wanted to determine whether the RMSD 
space explored by the inhibitor was different between the two approaches. 
Figure 3.9 compares the mean RMSD value of the binding region, as well as the 
maximum and minimum value, between the CRY1 and CRY2 simulation sets 
using the same reference structure for each simulation of a given inhibitor 
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(values are listed in Table 3.3). For most inhibitors, the mean, minimum, and 
maximum RMSD values are similar. Only in the case of the weak binding J1 
inhibitor does a large difference in maximum RMSD appear. These results do 
not guarantee that the exact same conformations are sampled by both 
approaches, nor do they indicate that the proportion of conformations sampled 
is similar. However, the results do indicate that long simulations do not explore 
RMSD space that is significantly farther away (higher RMSD values) than that 
sampled with an ensemble of diverse short simulations. 
It is important to note that the crystal structure is published with six 
magnesium ions, five of them nearby the binding region (13). The authors note 
three specific magnesium ions that seem particularly important structurally 
and also note that binding affinity dramatically decreases in the absence of 
magnesium. We chose not to include magnesium ions in this study, with the 
exception of the MG simulation, because the complex hydration and 
coordination geometries adopted by magnesium are difficult to model using a 
fixed charged model. To investigate whether simulations with magnesium 
differed from those without, a single 82 ns simulation was performed using the 
experimental coordinates for the J5R inhibitor, magnesium ions, 
crystallographic waters, and RNA (with the necessary sequence modifications 
to be consistent with the NMR structure). Also present was 200 mM KCl. No 
changes in the binding mode were observed. Figure 3.10 compares the regions 
of highest magnesium ion occupancy with the crystallographic locations of the 
magnesium ions. None of the highest occupancy locations observed in 
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simulation reproduce the exact coordination contacts observed in the crystal 
structure. The magnesium coordinated to N7 of A6 in the crystal structure 
moves to coordinate the phosphate groups of G30 and C31. The magnesium 
coordinated to both O4 of U14 and OP1 of U9 in the crystal structure loses the 
interaction to the phosphate and forms an interaction with O2 of C8 instead. 
Finally, both magnesiums located near G5 in the crystal structure move 
elsewhere. These results combined with the observation of stable simulations 
without magnesium ions suggest that magnesium ions do not appear to be 
critical in moderately high monovalent salt simulations (i.e., both had 200 mM 
KCl). This is consistent with in vitro binding assays in relatively high 
monovalent salt, and no magnesium, which observed expected binding behavior 
(12, 18). 
The highly stable solvated simulations of the RNA-inhibitor complex in 
the crystal conformation add support that the published structure is reasonably 
stable outside of the crystal lattice and therefore not strongly influenced by 
crystal packing forces. However, given the sampling limitations of MD 
simulations using current hardware, it is not possible to be sure that the crystal 
conformation represents the global minimum in the energy landscape. One way 
to investigate this is to determine whether the NMR distance restraints are 
satisfied by the crystal structure. To determine this, the r6-averaged distances 
for all atoms identified as NOE pairs by NMR were computed for the 200+ ns 
simulation of J4R from the CRY1 simulation set (this inhibitor structure is 
identical to that of the published NMR structure). The crystal structure and 
98 
 
several of the NOE restraints appear to be incompatible. Most of the large 
violations occur between inhibitor and RNA atom pairs, with the largest being 
those between the dimethylamino arms of the inhibitor and RNA residues A6 
and U12. It is likely that enforcing the NOE distance restraints during 
simulation of the crystal conformation would cause structural disruptions and 
form intractable “knots” due the large distance violations. However, a set of 
residual dipolar coupling (RDC) restraints were also obtained during collection 
of the NMR data (12). It is not immediately obvious how well the crystal 
conformation fits the RDC data. To test this, we performed a 5 ns simulation 
with RDC restraints enforced. No significant changes in the global structure or 
inhibitor binding contacts were observed. This suggests that although 
significant NOE violations are observed for the crystal conformation binding 
mode, it is consistent with the RDC data. Further research will be required to 
determine whether the NOE violations are simply due to data misassignment or 
whether a more complicated situation, such as multiple solution binding modes 
or RNA conformational dynamics, is responsible for the discrepancy.  
3.4.2 Energy analysis 
A major goal of this study was to determine whether energetic binding 
analyses of the simulation trajectories could reproduce the experimental 
trends in binding energy. This is a challenging problem given the high ionization 
states of the ligands and the relatively tight range of KD or ΔGbinding values 
estimated in experiment. Given the instability of the NMR1 simulation sets, we 
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only considered simulations performed with the crystal conformation. One of 
the quickest methods for obtaining binding energy data from MD simulations is 
to perform MM-GBSA/MM-PBSA analysis using the single trajectory method. The 
MM-GBSA and MM-PBSA results for both the CRY1 and CRY2 simulation sets are 
shown in Figures 3.11 and 3.12 (values are given in Table 3.4). Several 
observations can be made from the results. First, the magnitude of the binding 
energies is significantly larger than those observed experimentally. For MM-
GBSA, the range of binding energies for the various inhibitors is around -45 to -
65 kcal/mol. For MM-PBSA, the magnitude is slightly smaller with ranges around 
-30 to -55 kcal/mol. Obviously there is a significant difference between these 
values and the -5 to -8 kcal/mol range identified experimentally (Table 3.1). A 
variety of corrections can be considered to address this discrepancy. One 
explanation is that the free energy change upon RNA reorganization, which 
accompanies inhibitor binding, is not accounted for in the single trajectory 
approach. We have performed MD simulations and MM-GBSA analysis on the 
apo-RNA using the published NMR structure (10) as the initial conformation and 
can estimate this would add around +10 kcal/mol to the MM-GBSA binding 
energies. An additional energetic component, which we have not included in 
our MM-GBSA/MM-PBSA results, is the change in solute entropy upon binding. 
We have attempted to estimate the conformational entropy change for the 
inhibitors alone (estimates are between +0-25 kcal/mol, discussed below), but 
the size of the RNA presents a challenge to obtaining a full solute estimate. 
Additionally, the rotational and translational entropy loss upon ligand binding 
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would likely add in the range of +3-10 kcal/mol (63-68). Together, these 
corrections are in the range of +13-45 kcal/mol and could, in theory, bring at 
least the MM-PBSA results closer to experimental ranges. However, the raw 
binding energies from MM-GBSA/MM-PGBSA not only have a large magnitude but 
also large spread in values. For example, if we exclude the results for the J1 
inhibitor (due to uncertainty about its exact experimental binding energy), the 
range for MM-GBSA is ~10 kcal/mol and for MM-PBSA around ~20 kcal/mol. 
Given the similarity of the ligands and their binding mode with the RNA, it is 
unlikely that the aforementioned corrections for receptor reorganization and 
solute entropy could account for the large range in values. Finally, even if we 
ignore the incorrectly large range of binding energy, the relative trend in 
binding energy does not match what is observed experimentally (Table 3.1). 
The weakest binder, J1, can be distinguished from the other inhibitors, 
although less so with MM-PBSA than MM-GBSA. As for the other inhibitors, the 
trend does not correlate well. In particular, both MM-GBSA and MM-PBSA rank 
J2 as having an equal or lower binding energy than the J5 enantiomers, despite 
the fact that experimentally, J2 is among the weakest while J5 is among the 
strongest binders. It is not immediately clear why the MM-GBSA/MM-PBSA 
results do not match the experimental data, but it may be related to the 
failure of implicit solvent models to accurately model highly charged systems. 
In fact, it is known that the Hawkins, Cramer, and Truhlar GB model does not 




Given the poor performance of these implicit models, it is reasonable to 
seek an alternative calculation of the binding energy which includes the 
contribution of explicit solvent. We performed relative binding energy analysis 
on the explicitly solvated RNA-inhibitor systems using the total potential energy 
of the explicitly solvated trajectories directly. This was possible because all of 
the systems in the CRY1 and CRY2 simulation sets, with the exception of J1, 
had by design identical numbers of atoms (excluding the inhibitor atoms). 
Likewise, the LIG simulation set, which contained just the free inhibitors and 
solvent, also contained identical numbers of solvent atoms. Since the J1 
inhibitor has a different charge and therefore different number of counterions, 
it was excluded from consideration. The relative energetic contribution to 
binding for the trivalent inhibitors (J2-J6) can be calculated by subtracting the 
average potential energy of the free inhibitor simulations (LIG set) from the 
average potential energy of the bound inhibitor simulations (CRY1 or CRY2 
sets). Only the single long simulation strategy was used for the free inhibitor 
simulations (LIG) because the potential energies were tightly converged. 
Confirmation of this is demonstrated in the fact that the mean potential energy 
of all enantiomers are within expected error of one another (Table 3.5, fourth 
column). The results for the binding energy are shown in Figure 3.13. It should 
be noted that the absolute value of the binding energy is meaningless because 
it represents the force field energy difference of two systems with unequal 
atoms (i.e., ligand in solution and ligand bound to RNA). However, the relative 
energy differences can be compared because the relative difference between 
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the systems is identical, with the exception of the inhibitor atoms of interest. 
Several observations suggest that the relative binding energy values are more 
accurate than the MM-GBSA or MM-PBSA values. First, the range of binding 
energies is much smaller: ~6-7 kcal/mol. Second, the binding energies 
calculated from the CRY1 and CRY2 simulation sets are within error of one 
another, excepting J6SS which has a 0.9 kcal/mol difference in the error 
ranges. This was not the case for the implicit solvent approach, although it 
should be noted that the error values are larger for calculations involving 
explicit solvent. Third, the binding energies are internally consistent: the four 
J6 diastereomers, which contain two constrained rings of which one each is 
present in the J3 and J5 enantiomers, produce a binding energy trend which 
can be predicted from the J3 and J5 results. The binding energy of the S 
enantiomer is preferred for J5, whereas the R enantiomer is preferred for J3. 
Consistent with expectations, the J6SR inhibitor has the lowest binding energy. 
The lone exception to this internal consistency is J6SS of the CRY1 simulation 
set (the prediction is correct in the CRY2 results). Finally, if one averages the 
values of the enantiomers/diastereomers as an approximation of the 
experimental conditions (where stereochemistry was not considered), the 
trends match well with experiment (Figure 3.14, values are given in Table 3.6). 
The range of the binding energies calculated from simulation is somewhat 
larger than the range of binding energies from experiment (~4 kcal/mol vs. ~2 
kcal/mol). However the correct trend is observed as well as agreement 
between the single long trajectory and multiple short trajectory approaches. 
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This last observation is critical, given the small number of data points. Two 
completely independent approaches produce very similar results, suggesting 
that the results accurately reflect the underlying force field terms used to 
model the system.  
The difference between the implicit solvation results and the explicit 
solvation results can be highlighted by looking at cases where the inhibitor was 
improperly bound to the RNA. As noted in the methods section, the initial 
inhibitor poses were not chosen via a docking algorithm but rather by the crude 
RMS fit of the benzimidazole core atoms. While this ensured that critical 
hydrogen bonds were formed between the inhibitor and residue G33, it did 
nothing to prevent unfavorable clashes of the flexible inhibitor arms with the 
RNA. In nearly every initial inhibitor conformation, potential clashes were 
eliminated during the minimization step, and the resulting geometry resembled 
a reasonable binding pose. However, in a few cases, one of the inhibitor arms 
was improperly inserted through the back of the binding cavity. Despite the 
apparent strain in the geometry, some of these cases produced stable 
simulations without integration errors or energy instability. These cases were 
not included in the previously discussed energy analysis but they provide a 
useful test case in that an accurate representation of system energy should 
distinguish highly strained systems from those with an expected binding 
conformation. One such case of improper binding mode occurred with the J2 
inhibitor. For the multiple short simulation set CRY2, the range of mean GB 
potential energies of J2 in normal binding poses was -7913 to -7891 kcal/mol. 
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The mean GB potential energy of the strained conformation was  -7916 
kcal/mol, suggesting that it was actually a lower energy conformation. The MM-
GBSA binding energy computed using this strained conformation was -77 
kcal/mol, about 15 kcal/mol stronger binding than the average MM-GBSA 
binding value for J2 from the CRY2 simulation set. Likely, some portion of 
implicit solvation model incorrectly modeled this interaction. In contrast, using 
explicit solvent potential energies accurately identifies the strained J2 
conformation as a high energy outlier. The range of mean explicitly solvated 
potential energies for J2 from the CRY2 simulation set was -118790 to -118766 
kcal/mol, whereas the mean explicitly solvated potential energy for the 
strained conformation was -118761 kcal/mol. This trend, in which explicitly 
solvated energies more reliably predicted strained conformations than 
implicitly solvated potential energies, was true for other cases of strained RNA-
inhibitor conformations as well. 
In order to understand whether solvation energies played a role in the 
errors of the MM-GBSA/MM-PBSA results, we have performed further analysis of 
the LIG simulation set (in which the inhibitor was simulated freely in explicit 
solution without RNA). After postprocessing the trajectories using MM-GBSA 
analysis, a comparison of the solvated potential energy versus the GB potential 
energy was made (Figure 3.15, top, values are given in Table 3.7). As indicated 
by the trend line fit, the relative potential energies are similar whether using 
explicit solvation energies or the GB solvation energies. An RMS fit of explicit 
solvation energy values onto the implicit solvation values reveals that 
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differences range between 0.06-1.60 kcal/mol between the two methods. 
First, this shows that the MM-GBSA values are primarily enthalpic since they are 
similar to the explicit results (which are purely enthalpic). Second, it suggests 
that the likely origin of errors in the implicit solvation model is found in 
calculating the energy of the RNA-inhibitor complex. Similarly, if the free 
energy of solvation is computed (neglecting solute entropic terms) by 
subtracting the gas phase inhibitor energies from the solvated energies (either 
explicit or implicit), very similar trends between the explicit and implicit 
solvation model are observed (Figure 3.15, bottom). The large difference in the 
free energy of solvation (~13 kcal/mol) between J2/J3 and the rest of the 
inhibitors is troubling. The distinguishing feature between the two sets of 
inhibitors is whether or not a ring is formed on the oxygen side of the 
benzimidazole ring. Further research is necessary to understand this 
difference. 
As a final piece of energy analysis, we note that the experimental 
binding energy trends suggest that the use of ring constraints to reduce 
flexibility improves binding energy. Thus is it reasonable to expect that there 
are different entropic binding penalties for the inhibitors depending on the 
rigidity. Due to the difficulty in converging entropy estimates for large 
molecules, only the inhibitor was considered in these calculations. Two 
methods were used: quasi-harmonic analysis (58) and a configurational 
estimate based on bond, angle, and torsion probability distributions (59). The 
entropic energy penalties upon binding are given for each inhibitor based on 
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calculations from the CRY1 and LIG simulation sets (Figure 3.16, values given in 
Table 3.8). Convergence plots for these values are shown Figures 3.17 and 
3.18. The convergence plots demonstrate that the estimates are not reliably 
converged, even at greater than 700 ns for the free ligands, and thus must be 
interpreted very conservatively. One observation that is clear is that the quasi-
harmonic estimates have a much larger magnitude (approximately 5 to 25 
kcal/mol) than the conformational entropy estimates (0 to 5 kcal/mol). The 
large values produced by the quasi-harmonic approximation are likely due to an 
overestimation of the harmonic potential width for the free inhibitors because 
no attempt was made to differentiate between conformational energy minima 
and thus the estimated width is necessarily wider in order to cover a broader 
space. In contrast, the configurational estimate using probability distributions 
distinguishes both well width and conformational differences. In this case, the 
drawback is that individual degrees of freedom (bonds, angles and torsions) are 
assumed to be uncorrelated if only using the first-order approximation, which 
was done here. It is important to note that neither of these estimation 
techniques include the entropy loss due to changes in translational and 
rotational entropy upon ligand binding, which can be estimated to add an 
additional 3-10 kcal/mol (63-68). Given the assumptions made in the estimates 
and the lack of clear convergence, it is unwise to treat these values as anything 
more than qualitative observations. Given that caveat, we do find the average 
entropic penalty for the fully constrained inhibitors (J6 diastereomers) to be 
less than that of the less constrained (J2, J3, J4, and J5). 
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3.4.3 Molecular docking 
In order to test whether high throughput computational techniques could 
be used to predict accurate binding conformations between highly charged 
ligands and RNA, we performed docking analysis using the inhibitors shown in 
Figure 3.1 on the crystal RNA conformation with Dock 6.5. With the exception 
of J1, the weakest binding inhibitor considered, the docking pose with the best 
score for each inhibitor was consistent with the crystal structure binding mode 
and formed all of the critical binding contacts (Figure 3.19A,B). The J1 
inhibitor binds incorrectly to a major groove pocket on the opposite side of the 
RNA as the correct ligand pocket. It is unclear why J1 was so poorly docked, 
but it may reflect its weak binding value. Not surprisingly, the trend in docking 
scores did not match the experimental binding energy trend (Table 3.9). 
However, the docking results suggest that fairly accurate binding poses can be 
obtained for highly charged systems at inexpensive computational cost. Given 
the somewhat elaborate procedure we used to obtain charges for the 
inhibitors, we were interested in whether similar docking results could be 
obtained using a more traditional approach in which the semi-empirical AM1-
BCC charge model was used to assign atomic charged to the inhibitors. The 
results suggest that the more rigorous RESP approach can yield significant 
improvements in the results (Figure 3.19C and 3.20). This consideration is likely 
to be more important for multivalent ligands such as those studied in this work. 
Taken together, the results suggest that methods like Dock 6.5 using reliable 
scoring functions can be applied to generate reasonable binding modes which 
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may be further explored using more detailed simulations as presented in this 
work to get more reliable estimates of relative binding affinities. 
3.4.4 Novel Ligands 
Given the robustness of the crystal conformation across simulations of all 
the inhibitors in Figure 3.1, we were interested in how well ligands with a 
different scaffold could be accommodated by the binding site. Four novel 
ligands were designed which both exploit the known inhibitor interactions and, 
in certain respects, reduce the complexity of the ligand (Figure 3.21). These 
novel ligands have several advantages: less positive charge, fully aromatic rings 
which are less flexible, and no chiral centers. One of these ligands, N7, was 
stable in the receptor binding site during a 130 ns simulation (Figure 3.22). MM-
GBSA analysis on that trajectory yielded a binding energy of -61 kcal/mol, 
which is in the same approximate range as the known inhibitors, although our 
caution regarding implicit solvent models applies. Visual inspection of the 
trajectories suggests that further optimization of the dimethylamino arm 
length and orientation would likely produce improved binding. 
3.5 Discussion 
The presented results are relevant for computational drug development 
targeting the HCV domain II site as well as research on RNA-ligand binding in 
general. First, we have demonstrated that the crystal structure conformation 
appears to be more suitable than the NMR conformation for future inhibitor 
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development studies and that it forms stable RNA – ligand binding complexes 
using the AMBER ff12SB force field and explicit solvent. This result highlights 
the need for accurate initial structures when performing MD simulations. Due 
to the rugged energy landscape of RNA, incorrect initial structures will likely 
not reach the global minimum on tractable timescales. Since this concern is 
coupled with known force field flaws for RNA (a subject of ongoing research in 
our lab), it necessitates caution when performing MD simulations. For example, 
prior to the publication of the crystal structure, it was unclear if the structural 
instability of the NMR structure was due to inherent flexibility of the complex, 
force field flaws, incorrect experimental structure, or some combination of the 
three. The stability of the crystal structure in simulation and the preservation 
of the critical RNA-inhibitor contacts identified in the crystal structure suggest 
that our computational model is accurate, yet use of caution cannot be 
overstated. For example, it is still unclear how to resolve conflicts between the 
NOE restraint data from the NMR studies and the crystal structure.  
Even if an accurate simulation model is obtained, drug development 
efforts require accurate estimates of binding energy. Traditionally, MM-
GBSA/MM-PBSA trajectory postprocessing techniques have been moderately 
successful at predicting the binding free energy of protein-ligand systems. But 
such studies with highly charged ligands and highly charged receptors (e.g., 
RNA) are rare. As has been noted elsewhere (71), the binding free energy is 
largely determined by the difference between the desolvation energy and the 
bound complex energy. For a highly charged ligand-receptor interaction, both 
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of these values will be very large and thus errors in the method will dwarf the 
binding energy value. In this case, the error is likely not related to insufficient 
sampling (our estimated errors are reasonably small), but an error in the model 
used to describe the desolvation energy and the bound complex energy. As 
additional evidence, we have obtained very poor results from simulations of 
various RNA structures when using the Hawkins, Cramer, and Truhlar GB 
implicit solvent model (data unpublished). This could explain why the binding 
energies calculated from the explicit solvent systems compare more favorably 
with experiment than the binding energies obtained from implicit solvent 
approximations. Given the relative success of explicit solvent in comparison to 
implicit solvent for MD simulations of RNA, it is not surprising that energetic 
results utilizing the former solvation terms would produce better results. Along 
these same lines, the charge parameterization method appears to be crucial, 
at least for docking studies. This is not surprising given the large net charge of 
the inhibitors used in this study and the careful procedure reported here 
provides a useful framework for future charge parameterization on highly 
charged ligands. With care in ligand charge derivation, the docking results 
suggest that methods like Dock 6.5 with good scoring functions can accurately 
predict ligand binding modes. 
Finally, the data suggest that the multiple short simulation approach 
offers efficiency benefits over the single long simulation approach for energetic 
analysis. The mean explicit solvent binding energy values computed using both 
approaches were within error of each other for ten out of the eleven inhibitors 
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considered. In the case that differed, it seemed likely that the multiple 
simulation approach was correct based on the argument for internal 
consistency of stereochemical binding. The aggregate simulation time for the 
multiple simulation approach used only 480 ns (CRY2 set), significantly less 
than the 2616 ns of aggregate time used for the single simulation approach 
(CRY1 set). The drawback to the multiple simulation approach is that it does 
not ensure binding stability throughout the simulation. The 2 ns trajectories 
used are not long enough to allow clear structural transitions. Thus, if we had 
just used 2 ns trajectories, even 240 of them, the difference in stability 
between the NMR conformation and the crystal conformation would not have 








Figure 3.1. These previously identified inhibitors (18), which are studied in 
this work, bind to the HCV IRES subdomain IIa. Twelve stereochemically 
distinct inhibitors can be derived from the six structures shown here. The 
protonation state used in simulation is as depicted. The location of a 
stereocenter is indicated by a colored star. Throughout this paper the 
identity of the stereoisomer is given by adding R or S to the name designator 
(i.e., J3R, J3S, J4R, J4S, J5R and J5S). The J6 diastereomers are identified 
in the following manner, with the color of the R/S corresponding with 
colored star location:  J6RR, J6RS, J6SR, J6SS. The J4 inhibitor was used in 






Table 3.1. Experimental dissociation constants (μM) and the corresponding 
binding free energy (kcal/mol) determined previously by mass spectrometry 
(18). 
Inhibitor KD ΔGbinding 
(μM) (kcal/mol) 
J1 >100.00 -5.45 * 
J2 17.00 -6.50   
J3 3.50 -7.44   
J4 1.70 -7.87   
J5 0.86 -8.27   
J6 0.72 -8.37   
 
The free energy of binding was calculated according to the relation ΔG = RT 
ln(KD) at 298.15 K. *The exact dissociation constant is not known for J1, thus 







Figure 3.2. Despite similar sequences, the reported conformations of the 
inhibitor bound HCV IRES domain IIa differ between NMR and X-ray 
crystallography. (A) Secondary structure diagrams of the domain IIa 
constructs used in the NMR (12) and crystallography (13) studies. The hairpin 
sequence from the NMR study was used for all simulations in this study. The 
residues colored in red show the portion of the RNA which is identical in 
both published structures. Representative models depict the global structure 
of the NMR ensemble (B) and the crystal structure (C). The RNA backbone is 
emphasized with heavier width and the inhibitor is highlighted in green. The 









Figure 3.3. Stereo view (wall-eyed) of the inhibitor binding conformations 
observed in the experimental NMR ensemble (A) and the crystal structure 







Figure 3.4. A schematic of the crystal structure binding site in the plane of 
the J5 inhibitor. Residue labels are numbered according to the NMR hairpin 
sequence (Figure 3.2A). Critical contacts are indicated in dotted, colored 





Table 3.2. MD simulations performed in this work. 
Simulation 
Set 







NMR1 RNA1,Ligand3,K+,Cl-,TIP3P 12 1 12 232   
CRY1 RNA2,Ligand3,K+,Cl-,TIP3P 12 1 12 218 + 
CRY2 RNA2,Ligand3,K+,Cl-,TIP3P 12 20 240 2   
MG RNA2,J5R,Mg2+,K+,Cl-,TIP3P 1 1 1 82   
RDC RNA2,J4R,K+,Cl-,TIP3P 1 1 1 5   
NOV RNA2,Ligand4,K+,Cl-,TIP3P 4 1 4 70   
LIG Ligand3,K+,Cl-,TIP3P 12 1 12 594 + 
1RNA receptor in the NMR conformation. 2RNA receptor in the crystal 
conformation.  3Indicates that the 12 ligands are those described in Figure 
3.1. 4Indicates that the 4 ligands are those described in Figure 3.11. 
5Simulation length represents the simulation time for each simulation 
(multiply Total Simulations by Simulation Length to get the aggregate time). 









Figure 3.5. An example of error analysis using the re-blocking procedure. 
The convergence of the standard error of the mean (SEM) with increasing 
block size (ps) is depicted for the explicitly solvated potential energy 
(kcal/mol) taken from the J4R simulation of the CRY1 set. According to our 
protocol, where the maximum observed value is chosen as the error, this 







Figure 3.6. The binding region RMSD (Å) reveals that over the course of the 
simulation time (ns) the CRY1 (black) simulation set is much more stable 
than the NMR1 (red) set. Each simulation set is represented by twelve lines 
which correspond to twelve stereochemically distinct inhibitors (Figure 3.1). 
The atoms considered in the binding region are defined to be the heavy 
atoms in residues 5, 6, 32, 33, 34 and the inhibitor. The first frame of each 
production simulation was used as the RMSD reference structure for that 
simulation. For clarity, the RMSD values have been smoothed with a 2500 







Figure 3.7.  Structural ensembles made from the final frames of the NMR1 
(A) and CRY1 (B) simulation sets as defined in Table 3.2.  The ensembles 
were RMS fit using residues 5,6,33, and 34.  The final inhibitor position is 









Figure 3.8. The NMR conformation can convert to a crystal-like 
conformation during simulation.  Within 50 ns, the critical RNA-inhibitor 
distances (Å) of the J5R trajectory from the NMR1 simulation set (A) are 
similar to those observed in the J5R trajectory from CRY1 set (B).  The line 
colors correspond to the distances indicated in Figure 3.4.  Data are 







Figure 3.9.  Comparison of the binding region RMSD (Å) space explored by 
the CRY1 (top) and CRY2 (bottom) simulations suggests that the 
conformations explored by each approach are not vastly different.  The 
colored bars represent the mean value and the error bars show the minimum 
and maximum values.  The mean value for each of the twenty individual 
CRY2 simulations is depicted by “x” data points (bottom), whereas the bar 
shows the overall mean value.  A single reference structure, for each RNA-
inhibitor complex, was used to compute the RMSD values.  These values are 





Table 3.3.  The binding region RMSD (Å) values for the CRY1 and CRY2 
simulations sets.   
 
Ligands 
CRY1 RMSD CRY2 RMSD 
Avg Min Max Avg Min Max 
J1 0.8 0.3 1.9 0.7 0.3 1.4 
J2 0.9 0.4 1.6 0.8 0.5 1.6 
J3R 0.8 0.3 1.4 0.8 0.4 1.5 
J3S 0.8 0.4 1.5 0.8 0.4 1.4 
J4R 0.7 0.3 1.2 0.7 0.3 1.2 
J4S 0.8 0.3 1.6 0.8 0.3 1.5 
J5R 0.8 0.4 1.3 0.8 0.4 1.4 
J5S 0.7 0.4 1.4 0.7 0.3 1.4 
J6RR 0.9 0.5 1.4 0.8 0.5 1.3 
J6RS 1.0 0.3 1.5 0.9 0.4 1.4 
J6SR 0.8 0.3 1.3 0.8 0.4 1.4 
J6SS 1.0 0.4 1.5 0.8 0.4 1.5 
 





Figure 3.10.  Stereo views (wall-eyed) of the Mg2+ binding locations in 
simulation (top) and in the experimental structure (bottom) reveal subtle 
differences in the binding location but very little difference in the inhibitor 
binding mode.  In the simulation structure, the green surfaces indicate 
regions of high Mg2+ density as determined by grid analysis and are overlaid 
on the average structure of the RNA-inhibitor complex.  Green spheres in the 
experimental structure indicate regions of electron density that correspond 







Figure 3.11.  MM-GBSA binding energy results for the CRY1 (top) and CRY2 
(bottom) simulation sets.  The mean value for each of the twenty individual 
CRY2 simulations is depicted by “x” data points (bottom), whereas the bar 
shows the overall mean value.  All data units are kcal/mol and the specific 







Figure 3.12.  The MM-PBSA binding energy (kcal/mol) results for the CRY1 
(top) and CRY2 (bottom) simulation sets.  The average value for each of the 
twenty CRY2 simulations is depicted by “x” data points (bottom).  Values are 





Table 3.4.  The MM-GBSA and MM-PBSA binding energies (kcal/mol) for the 
CRY1 and CRY2 simulation sets.   
 
 CRY1 CRY2 CRY1 CRY2 
 Ligands MMGBSA MMGBSA MMPBSA MMPBSA 
J1 -45.9 (0.4) -44.2 (0.5) -35.3 (1.0) -30.5 (0.7) 
J2 -63.0 (1.0) -61.6 (0.8) -46.0 (1.3) -39.7 (1.0) 
J3R -65.6 (0.6) -66.5 (0.5) -50.3 (1.6) -50.3 (0.7) 
J3S -65.8 (0.6) -66.5 (0.6) -56.3 (2.2) -51.0 (1.0) 
J4R -67.0 (0.5) -62.1 (0.8) -50.4 (0.8) -42.4 (1.0) 
J4S -64.0 (1.0) -58.6 (0.7) -48.4 (1.7) -38.2 (1.1) 
J5R -63.2 (1.0) -58.3 (0.9) -42.2 (1.0) -34.0 (1.1) 
J5S -57.5 (0.6) -55.8 (0.5) -34.7 (0.6) -28.9 (0.8) 
J6RR -63.1 (0.5) -63.6 (0.6) -49.8 (0.5) -47.7 (0.8) 
J6RS -64.2 (0.5) -62.9 (0.5) -52.8 (0.7) -47.7 (0.7) 
J6SR -60.9 (0.3) -61.1 (0.5) -43.9 (0.6) -41.4 (1.1) 
J6SS -59.1 (0.7) -60.3 (0.3) -41.2 (1.1) -41.2 (0.7) 
 






Table 3.5.  The data values (kcal/mol) for the explicit solvent potential 
energy binding calculations from the CRY1, CRY2, and LIG simulation sets.  
  
  CRY1 CRY2 LIG CRY1-LIG CRY2-LIG 
Lig. TIP3P EPtot TIP3P EPtot TIP3P EPtot TIP3P EPtot TIP3P EPtot 
J1 -118851.9 (1.1) -118850.1 (1.1) -20523.7 (0.4)         
J2 -118774.4 (1.5) -118774.4 (1.4) -20756.2 (0.2) -98018.2 (1.6) -98018.2 (1.6) 
J3R -118750.2 (2.5) -118747.0 (1.5) -20727.0 (0.2) -98023.1 (2.7) -98020.0 (1.7) 
J3S -118744.6 (1.8) -118745.4 (1.1) -20726.8 (0.2) -98017.9 (2.0) -98018.7 (1.3) 
J4R -118772.3 (2.0) -118772.4 (1.4) -20750.4 (0.2) -98021.8 (2.1) -98022.0 (1.5) 
J4S -118768.9 (2.9) -118770.9 (1.2) -20750.0 (0.2) -98018.9 (3.0) -98020.9 (1.4) 
J5R -118761.7 (1.9) -118760.5 (1.0) -20739.9 (0.2) -98021.8 (2.0) -98020.6 (1.2) 
J5S -118762.0 (1.4) -118762.6 (0.9) -20739.5 (0.3) -98022.5 (1.7) -98023.2 (1.2) 
J6RR -118727.8 (2.0) -118730.5 (1.1) -20707.5 (0.3) -98020.3 (2.3) -98023.0 (1.4) 
J6RS -118734.2 (2.1) -118736.9 (1.3) -20717.4 (0.3) -98016.8 (2.4) -98019.5 (1.6) 
J6SR -118742.1 (1.6) -118742.4 (1.2) -20717.5 (0.1) -98024.6 (1.7) -98024.9 (1.3) 
J6SS -118732.8 (1.7) -118728.1 (1.4) -20707.8 (0.3) -98025.0 (2.0) -98020.4 (1.7) 
 
 
Note: values in the fifth and sixth columns correspond to those displayed in 







Figure 3.13.  Relative binding energy using the solvated potential energy 
difference (see text) from the CRY1/LIG (top) and CRY2/LIG (bottom) 
simulation sets.  Data for the J1 inhibitor are not shown due to the 
difference in charge with the rest of the inhibitors which results in systems 
that cannot be directly compared.  All data units are kcal/mol and the 







Figure 3.14.  Stereochemically averaged relative binding energy using the 
solvated potential energy difference (see text) for the CRY1/LIG (top, 
striped bars) and CRY2-LIG (top, solid bars) simulation sets.  Data for the J1 
inhibitor are not shown due to the difference in charge with the rest of the 
inhibitors which results in systems that cannot be directly compared.  
(Bottom) Previously reported experimental binding energies (18).  All data 
units are kcal/mol and the specific values for both the top and bottom chart 





Table 3.6.  Stereochemically averaged simulation and experimental binding 
energies (kcal/mol).   
 
  CRY1-LIG CRY2-LIG Experimental 
Ligands TIP3P EPtot TIP3P EPtot Free Energy 
J2 -98018.2 (1.6) -98018.2 (1.6) -6.5   
J3 -98020.5 (2.3) -98019.3 (1.5) -7.4   
J4 -98020.4 (2.6) -98021.4 (1.5) -7.9   
J5 -98022.2 (1.8) -98021.9 (1.2) -8.3   
J6 -98021.7 (2.1) -98021.9 (1.5) -8.4   
 
 
Note: the simulation binding energy values (from explicit solvent potential 
energies) were averaged based on stereochemistry from values listed in the 







Figure 3.15.  Inhibitor solvation energy (kcal/mol) analyses for the LIG 
simulation set reveal that implicit and explicit solvation models yield similar 
results.  (Top) Plot of the average GB potential energy versus the average 
solvated potential energy.  A linear regression trendline fit is shown.  
(Bottom)  Solvation energies for GB solvent model (left, light bars) and 
TIP3P explicit solvent (right, dark bars).  Solvation energy is determined by 
subtracting the gas phase potential energy from the solvated potential 





Table 3.7.  The solvated potential energy (kcal/mol) and free energy of 
solvation (kcal/mol) for inhibitors in both implicit and explicit solvent.   
 
  Ligand EPtot Ligand EPtot ΔGsolvation ΔGsolvation 
Ligands GB solvent TIP3P GB solvent TIP3P 
J1 5.81 (0.02) -20523.7 (0.4) -159.5 (0.0) -20689.0 (0.4) 
J2 11.27 (0.02) -20756.2 (0.2) -278.6 (0.1) -21046.1 (0.2) 
J3R 38.62 (0.09) -20727.0 (0.2) -279.0 (0.1) -21044.7 (0.2) 
J3S 38.61 (0.06) -20726.8 (0.2) -279.1 (0.1) -21044.5 (0.3) 
J4R 16.61 (0.03) -20750.4 (0.2) -293.7 (0.1) -21060.7 (0.2) 
J4S 16.61 (0.02) -20750.0 (0.2) -293.6 (0.1) -21060.2 (0.2) 
J5R 28.33 (0.15) -20739.9 (0.2) -292.8 (0.2) -21061.0 (0.2) 
J5S 28.47 (0.19) -20739.5 (0.3) -292.6 (0.2) -21060.5 (0.3) 
J6RR 59.56 (0.22) -20707.5 (0.3) -291.5 (0.3) -21058.6 (0.4) 
J6RS 49.68 (0.30) -20717.4 (0.3) -293.0 (0.4) -21060.1 (0.3) 
J6SR 49.40 (0.10) -20717.5 (0.1) -293.3 (0.2) -21060.2 (0.2) 
J6SS 59.46 (0.24) -20707.8 (0.3) -291.6 (0.3) -21058.8 (0.3) 
 
 
Note: Data values for solvated potential energies and free energy of 
solvation as depicted in Figure 3.15.  The free energy of solvation was 
determined by subtracting the solvated potential energy from the in vacuo 







Figure 3.16.  Similar trends, but differing magnitudes, are observed when 
comparing the ligand binding entropy penalty (kcal/mol) using the quasi-
harmonic method (top) and the first-order configuration entropy (bottom).  
The penalty is calculated as –TΔS, where T is 298.15 K and ΔS is the absolute 
ligand entropy in free solution (from the LIG simulation set) subtracted from 
the ligand entropy in complex (from the CRY1 simulation set).  Convergence 
of these values is depicted in Figures 3.17 and 3.18 and the data values are 





Table 3.8.  The binding entropy penalty (kcal/mol) calculated from the 
CRY1 and LIG simulation sets.   
 
  Quasi- Configurational 
Ligands Harmonic Entropy 
J1 6.5 0.9 
J2 20.4 2.9 
J3R 23.9 5.2 
J3S 22.0 4.3 
J4R 25.4 4.6 
J4S 16.4 3.0 
J5R 23.4 3.3 
J5S 27.2 5.1 
J6RR 14.0 2.9 
J6RS 5.8 -0.2 
J6SR 10.3 2.6 
J6SS 11.4 2.3 
 
 
Note: the penalty is calculated as –TΔS, where T is 298.15 K and ΔS is the 
absolute ligand entropy in free solution (from the LIG simulation set) 
subtracted from the ligand entropy in complex (from the CRY1 simulation 








Figure 3.17.  The quasi-harmonic entropy (cal/mol∙K) for inhibitors in free 
solution (top) and in complex with RNA (bottom).  The horizontal axis is time 
(ps).  Colors correspond to the following inhibitors:  J1 (red), J2 (orange), J3 
(yellow), J4 (green), J5 (blue), J6RR and J6SS (purple, solid), J6RS and J6SR 







Figure 3.18.  The first-order configurational entropy (cal/mol∙K) for 
inhibitors in free solution (top) and in complex with RNA (bottom).  The 
horizontal axis is time (ps).  Colors correspond to the following inhibitors:  
J1 (red), J2 (orange), J3 (yellow), J4 (green), J5 (blue), J6RR and J6SS 
(purple, solid), J6RS and J6SR (purple, dashed).  Data were taken from the 







Figure 3.19.  Docking results using the crystal structure receptor 
conformation.  (A) Overlay of best scoring docking poses for each of the 
twelve stereochemically distinct inhibitors on the crystal structure receptor 
RNA.  The only inhibitor that did not bind in the expected orientation was 
the weakest binder, J1.  (B) Close-up view of the of the inhibitor docking 
poses in the binding site.  (C) Comparison of the AM1-BCC (black) and RESP 
(red) charge methods:  the best scoring pose for each of the twelve 
inhibitors is plotted with its corresponding RMSD value (experimental crystal 
structure used as reference, benzimidazole core atoms only).  The outlier 





Table 3.9.  The best docking grid scores for the binding of the twelve 
stereochemically distinct inhibitors represented in Figure 3.1 to the RNA 
target in the crystal conformation.   
 
  Docking 















Note: docking was performed with DOCK 6.5 and the data shown used the 







Figure 3.20.  Comparison of the average core atom RMSD values (with 
respect to the crystal structure inhibitor core atoms) for the five best 
scoring docking poses of each inhibitor suggests that the RESP method yields 















Figure 3.22.  The binding region RMSD (Å) time series (ns) for the four 
trajectories in the NOV1 simulation set. The binding region is defined to 
include residues 5,6,32,33,34 and the inhibitor.  The first frame of 
production simulation was used as the RMSD reference structure for each 
trajectory.  The RMSD values have been smoothed with a 2500 data point 
running average.  Colors refer to inhibitors listed in Figure 3.21 as follows: 
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4.2 Introduction 
RNA takes on many essential roles in biology, from information encoding 
to catalysis to regulatory functions (1). Molecular dynamics (MD) simulations 
provide a critical connection between structural theory and experimental data 
for RNA as well as other biomolecules (2-5). Unfortunately, the force fields 
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which underlie the physical representation of RNA tend to be less reliable than 
those used for proteins and have required numerous refinements over the past 
several years (6-11). This is likely due to a variety of factors which could 
include the highly charged and highly flexible RNA backbone. As we and others 
continue efforts at force field development, it has become apparent that a 
time-efficient and cost-effective method is necessary for producing 
biomolecular simulation data, from which quantitative results defining the 
ensemble of sampled conformations can be obtained and the underlying force 
field evaluated. Conventional MD simulations, typically performed at laboratory 
temperatures in order to match experiment, often require cost-prohibitive 
timescales and/or special purpose hardware to produce converged results (12). 
Additionally, cost-saving approaches such as implicit solvation, which reduces 
the total degrees of freedom in the system, tend to result in major 
conformational distortions for many RNA systems (13, 14) (and as is 
demonstrated in the results of this work). To address the need for efficient 
simulation methods for generating well-converged conformational ensembles 
required for force field development and assessment, we turned to approaches 
from the widely studied field of enhanced sampling (15-17). 
Replica exchange MD (REMD) is a commonly used method for enhanced 
sampling which deploys an ensemble of independent system replicas, or MD 
simulations, that exchange various properties (18, 19). By allowing a system 
replica at target conditions (such as the laboratory temperature) to exchange 
with system replicas at conditions which favor sampling (such as higher 
151 
 
temperatures), REMD enhances conformational sampling on a rugged landscape 
while maintaining a Boltzmann-weighted ensemble at each target condition 
(17). Due to the computational cost of simulating multiple system replicas, 
temperature REMD is often used with implicit solvent which reduces the 
number of degrees of freedom in the system, requiring fewer replicas to span a 
given temperature regime while maintaining acceptable exchange ratios. 
Unfortunately, as noted above, RNA simulations in implicit solvent tend to 
produce poor results. There are a variety of small systems that have been 
studied using REMD with explicit solvent, including proteins (20-28), DNA(29, 
30), and RNA (31-34). In most cases, convergence of the REMD ensemble is 
discussed in qualitative terms, if at all, and typically only one REMD simulation 
is performed for each condition of interest. In this work we aim to provide a 
more detailed understanding of convergence in explicit solvent. Due to our 
interest in obtaining quantitative results, we chose to study two small systems 
in order to reduce computational cost: alanine dipeptide and a tetranucleotide 
RNA, rGACC (Figure 4.1). Alanine dipeptide is a frequently used test molecule 
due to its simplicity (35-38) and rGACC is optimal because it is small, has 
detailed NMR data published regarding its structure, and has been studied 
previously using conventional MD (39). 
Finally, in addition to traditional REMD, we also investigate two methods 
which were previously reported to offer the benefits of REMD at reduced 
resource cost: TIGER2 (38) and reservoir REMD (R-REMD) (40). The TIGER2 
method reduces the number of replicas required for the ensemble by 
152 
 
incorporating a velocity rescaling and thermal equilibration step both prior to 
and immediately following the exchange attempt. This added step shifts the 
potential energy distribution of high temperature replicas nearer to the 
distribution of the baseline temperature replica and allows exchanges to occur 
which would otherwise be improbable due to the large potential energy 
distribution spacing. The other method, R-REMD, enhances convergence by 
adding a high-temperature structure reservoir to the top of the REMD 
temperature ensemble. Thus, a replica at the highest target temperature can 
exchange with the pregenerated reservoir and the costly wait associated with 
traversing energy barriers is overcome by exchange. In effect, the reservoir 
drives convergence of the entire REMD ensemble. This approach has been 
reported previously with implicit solvent (40, 41), and in explicit solvent with 
multiple reservoirs for the disordered Abeta(21-30) peptide (42). Here, we 
apply the single reservoir approach and explore convergence for RNA. Quite 
surprisingly, even with a relatively small RNA system like rGACC, the results 
suggest that standard REMD methods may require over 2 µs per replica for 
convergence, and even with reasonable starting reservoirs, R-REMD still 
requires 20 – 100 nanoseconds per replica, depending on the required accuracy 




4.3.1 System building 
Two explicitly solvated systems were studied in this research: alanine 
dipeptide and the RNA tetranucleotide rGACC (Figure 4.1). Alanine dipeptide 
was built by capping an alanine residue with ACE (i.e., CH3CO−) and NME (i.e., 
−NHCH3), using AMBER’s LEaP program and parameterized with the AMBER 
ff12SB force field (43, 44). To solvate the system, 544 TIP3P water molecules 
(45) were added to a cubic periodic box around the solute. The system size was 
chosen to match and be consistent with the systems used in previous studies 
with the TIGER2 protocol (38). 
The initial conformation for the RNA tetranucleotide, rGACC, was taken 
from an A-form portion of a RNA crystal structure (PDB: 3G6E, residues 2623-
2626). The RNA, parameterized with the ff12SB force field (note, for nucleic 
acids this is identical to ff10 which was released with AMBER11), was solvated 
with 2500 TIP3P water molecules in a truncated octahedron periodic box and 
the total system charge was neutralized with three sodium ions. Additional salt 
was not added to be consistent with previous computational studies by Turner 
and co-workers (39). This RNA was previously studied with AMBER ff99 force 
field as well as a modified variant by Turner and co-workers (9), which includes 
corrections to the χ torsion parameters. We chose to use the ff12SB force field 
for the following reasons: it includes backbone torsion corrections (6), higher 
accuracy χ torsion corrections (in comparison to the Turner variant) (8), and 
has been tested on larger, more representative RNA structures (7, 46, 47). 
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4.3.2 System heating and equilibration 
All simulations were performed with AMBER12 (43) using either the 
PMEMD or SANDER programs. PMEMD was used when possible due to its superior 
computational performance and parallel efficiency. However, PMEMD does not 
(yet) support R-REMD simulations and thus SANDER was used for these 
simulations. Additionally, TIGER2 simulations are not implemented in AMBER 
and thus an in-house script was used as a wrapper to implement the simulation 
cycle (details discussed later). Prior to production simulations, both the alanine 
dipeptide and RNA systems were energy minimized and equilibrated. Energy 
minimization was performed with 25 kcal/mol-Å2 atomic positional restraints 
on the solute and consisted of 1000 steps with the steepest descent algorithm 
followed by 1000 steps with the conjugate gradient algorithm. Following 
minimization, the systems were heated from 10 K to 150 K at constant volume 
with 25 kcal/mol-Å2 atomic positional restraints on the solute using 1 fs 
timestep. This heating step was accomplished with 100 ps of MD simulation for 
the alanine dipeptide system and 1 ns for the RNA system. During heating, the 
temperature was controlled using a Langevin thermostat with a collision 
frequency of 2.0 ps-1. Further heating to the target temperature (300 K in most 
cases) was performed at constant pressure using a weak-coupling algorithm 
(48), a pressure relaxation time of 1 ps, 5 kcal/mol-Å2 atomic positional 
restraints on the solute, and the same thermostat, timestep, and duration 
settings as the previous heating step. After reaching the target temperature, 
the system was further equilibrated (1 ns for alanine dipeptide, 5 ns for the 
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RNA) with 0.5 kcal/mol-Å2 positional restraints on the solute using weaker-
coupling constant pressure relaxation time of 5.0 ps. The integration time step 
during this equilibration step was 2 fs and temperature regulation the same as 
previous steps. For all explicit solvent MD in this research, the nonbonded 
direct space cutoff was set to 8.0 Å and the default AMBER12 particle mesh 
Ewald (49) settings were used to control reciprocal space calculations. SHAKE 
constraints (50) with a tolerance of 0.00001 Å were used to eliminate short 
timescale bond vibrations between hydrogen atoms and heavy atoms. 
4.3.3 Production MD 
Table 4.1 provides a list of the production simulations discussed in this 
research. In the text below, we provide details on the settings for each type of 
simulation: Conventional MD, TIGER2, REMD, and R-REMD. 
Conventional MD: Both constant pressure (NPT) and constant volume 
simulations (NVT) were performed in the conventional manner. The constant 
pressure simulations (ALA-NPT and RNA-NPT in Table 4.1) were intended to 
match typical simulation protocols. The time step was set to 2 fs and a weak 
coupling algorithm governed both the temperature and pressure regulation 
with a relaxation time of 10 ps. Constant volume simulations (ALA-NVT, ALA-
398, RNA-398) used 2 fs time step and the Langevin thermostat with the 
collision frequency set to 10 ps-1 for alanine dipeptide, to be consistent with 
previous work (38), and 2 ps-1 for the RNA.  
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TIGER2: A method for enhanced sampling, named TIGER2 (38), has been 
previously described and offers the benefits of temperature REMD with reduced 
computational cost. The TIGER2 algorithm is not implemented in AMBER, but 
can be achieved fairly easily with a simple wrapper script. Our implementation, 
which closely followed the published description, uses repeated cycles of 
PMEMD calculations for the MD steps and a Perl script to perform the velocity 
rescaling and Metropolis selection steps. Four replicas were used at the 
following temperatures: 300, 377, 476, and 600 K. A typical cycle consists of 
four steps starting from initial systems all at 300K: 1) velocity rescaling to one 
of the four assigned temperatures followed by thermal equilibration, 2) 
dynamics sampling at the assigned temperature, 3) velocity rescaling of all 
replicas back to 300 K followed by thermal equilibration, and 4) exchange 
attempt and temperature reassignment. The last step consists of the following 
substeps: a candidate system from the three highest temperatures is randomly 
selected (using Perl’s rand function) for an exchange attempt with the baseline 
temperature replica (300 K), the exchange probability is determined by the 
Metropolis criterion, the result assigns one of the two considered replicas to 
the baseline temperature, and the remaining systems are assigned to the 
higher temperatures according to their system potential energies (higher 
energies are given a higher temperature). For all TIGER2 simulations, the 
heating and production sampling time periods were 1 ps each. The cooling 
period was varied between three time periods, 1ps, 2ps, and 5ps, as this time 
period had a large affect on exchange acceptance (ALA-TIG-1, ALA-TIG-2, and 
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ALA-TIG-3 in Table 4.1, respectively). Similar to what was used in the 
reference publication, we used a Langevin thermostat collision frequency of 25 
ps-1 during the heating and quenching portions of the cycle and 10 ps-1 during 
the sampling portion.  
REMD: Traditional REMD calculations were performed using AMBER’s 
PMEMD program. The temperature intervals between replicas were estimated 
using an online generator at http://folding.bmc.uu.se/remd (51) and are listed 
in Table 4.2. These distributions led to exchange rates between 0.15-0.30 for 
the ten replica simulations and 0.15-0.40 for the twenty-four replica 
simulations. All REMD simulations were performed at constant volume as AMBER 
does not support constant pressure for REMD. It has been noted that the 
hydrophobic effect will be increased at high temperatures for constant volume 
simulations (52, 53). The extent of this phenomenon at high temperatures for 
the systems studied here and its influence on lower temperature 
conformational results remains unclear. Prior to production simulations, a 200 
ps heating period was employed to equilibrate each replica to the assigned 
initial temperature. Temperature was controlled with the Langevin thermostat 
set to a collision frequency of 10 ps-1 for alanine dipeptide and 2 ps-1 for the 
RNA. A time step of either 1 or 2 fs was used and is noted in Table 4.1. The 2 fs 
timestep is typically the preferred value for computational performance 
reasons, but 1 fs was used for simulations with high temperatures (~600 K) out 
of caution. The exchange attempt interval was set to either 0.2 or 1.0 ps and is 
noted in Table 4.1. An exchange attempt interval of 1 ps is more commonly 
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used. However, the use of a shorter interval may improve convergence (54, 
55). The value we chose was arbitrary in some cases but dependent on the 
hardware being used in others. For instance, the GPU simulations are fast 
enough that we were concerned about a performance drop if the exchange 
attempt interval was too small. To be consistent with the GPU simulation (RNA-
REMD-1), we used a 1 ps exchange attempt interval for the R-REMD simulations 
of the RNA system even though they were performed on CPUs. In the case of 
alanine dipeptide, a 0.2 ps exchange attempt interval was used for all REMD 
simulations except ALA-24REMD, which was intended to mimic a more 
traditional/conservative approach (1 ps exchange attempt interval and 1 fs 
timestep). In addition to explicit solvent REMD simulations, we also performed 
one implicit solvent REMD simulation (RNA-REMD-GB). Implicit solvation was 
implemented using the Hawkins, Cramer, and Truhlar generalized Born (GB) 
model (56, 57) with a surface area contribution to the solvation term computed 
by the LCPO model (58). A salt concentration of 200 mM was approximated 
using Debye-Hückel screening. The Langevin thermostat was used to control 
temperature with a collision frequency of 2 ps-1. An infinite cutoff was 
employed for the nonbonded cutoff and SHAKE constraints were used to 
eliminate high frequency bond vibrations between hydrogen atoms and heavy 
atoms. All analysis of the traditional REMD simulations with RNA discarded the 
first 50 ns as equilibration (the initial structure of each replica was identical so 
we use the term equilibrate here to mean that a variety of structures are being 
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sampled at each temperature level as determined by inspecting the RMSD plot 
(Figure 4.2)). 
R-REMD: In contrast to traditional REMD, the highest temperature replica 
in R-REMD simulations exchanges with a pregenerated reservoir of structures. 
This method was previously introduced by Okur et al. (40, 41) and tested in 
implicit solvent. In the current work, reservoirs were generated at 398 K using 
conventional MD simulations and consisted of high precision 
coordinate/velocity frames saved every 10 ps. The potential energy of each 
frame in the reservoir was computed and used in the exchange calculation 
during the R-REMD simulation with a 1/N non-Boltzmann weighting assumed for 
each frame. Exchange between highest temperature replica and the reservoir 
was ~0.47 for the alanine dipeptide simulations and ~0.33 for RNA simulations. 
All other simulation settings were identical to those used in the traditional 
REMD simulations. Note, the “-S” and “-L” suffixes stand for small and large 
reservoirs, respectively, in Table 4.1. 
4.3.4 Hardware 
All simulations were performed using traditional CPU clusters at a 
variety of resource locations with the exception of the RNA-NPT, RNA-398, and 
RNA-REMD-1 simulations, which were performed on GPUs. The CPU clusters 
include NICS Kraken, SDSC Gordon, and the University of Utah CHPC clusters. 
The GPU simulations were performed using the CUDA enabled PMEMD code (59) 
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on GPU accelerated nodes (NVIDIA Tesla M2090 GPUs) at either NICS Keeneland 
or the University of Utah CHPC.  
4.3.5 Conformational analysis 
The REMD algorithm implemented in AMBER specifies that when an 
exchange attempt is successful, replicas will exchange thermostat 
temperatures (the alternative being the exchange of system coordinates). This 
results in each replica containing simulation data from a variety of 
temperatures. Often, the researcher is most interested in data for a specific 
temperature and thus the REMD trajectory ensemble must be sorted such that 
contiguous data are obtained for each temperature level. In this chapter, we 
refer to such a process as “sort by temperature.” Alternatively, it is 
occasionally of interest to study the data directly for each replica without 
sorting by temperature (as we do for our ensemble RMSD profile analysis). We 
will refer to this as “sort by replica.” In order to sort by temperature we used a 
development version of AMBER’s Cpptraj. Conformational analysis, including 
RMSD profiles, clustering, principal component analysis, and torsion and 
distance calculations, were performed using a combination of AMBER’s Ptraj 
and Cpptraj programs and in-house Perl scripts. All RMSD analysis was made 
using a common reference structure, which ensured that results could be 
compared. The common reference structure for both alanine dipeptide and 
rGACC was generated by GB energy minimization of initial build structure for 
each molecule. RMSD analysis was performed with mass-weighting using only 
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heavy atoms for alanine dipeptide and all atoms for the RNA. Clustering of the 
RNA simulations was performed with Ptraj using the “averagelinkage” 
agglomerative algorithm, a critical distance epsilon value of 2.3 Å, and a 
variable sieve value which ensured that the initial clustering pass contained 
~5000 frames. The sieve, which uses an initial subset of randomly chosen 
frames to define the clustering divisions, was required because memory 
limitations do not allow complete clustering of a large number of frames. Thus 
five independent cluster analyses were performed for each simulation of 
interest and an average and standard deviation was reported. Animation of the 
PCA eigenvectors was performed using PCAsuite (60). Molecular graphics 
images were generated using UCSF Chimera (61). 
4.4 Results and Discussion 
4.4.1 Alanine dipeptide conformations and convergence 
Due to its small size and simple structure, a solvated alanine dipeptide 
system is convenient for quick testing and demonstrating proof of principle. 
Thus we began by studying the feasibility of various explicitly solvated REMD 
simulations with this system. The primary purpose of these initial investigations 
was to demonstrate that a given simulation can reliably sample the 
conformational space of the solute of interest. One convenient method for 
observing the sampled space is to generate a histogram profile of the atomic 
RMSD values with respect to a common reference structure. We found that 
conventional MD (both constant volume and constant pressure), traditional 
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REMD, and R-REMD produce nearly indistinguishable RMSD profiles (Figure 4.3). 
We note here that RMSD profiles represent a necessary but not sufficient test 
of convergence. Thus they are useful as an initial test to compare whether 
ensembles from two independent simulations overlap. More detailed 
conformational analysis is required (and provided later) to confirm this in 
situations where multiple conformations occupy the same RMSD space. 
In order to gauge the convergence of these simulations, a more in-depth 
analysis is required. By plotting the cumulative RMSD profile over simulation 
time (Figure 4.4), it is possible to observe the time convergence at any point 
along the profile, such as the frequency maxima (Figure 4.5). From this 
convergence plot we find that REMD calculations require significantly less time 
to reach convergence than conventional MD and R-REMD calculations are nearly 
converged from the beginning of the simulation (the latter observation was also 
made by Okur et al. (40)). A comparison of the ten replica REMD simulation 
(ALA-10REMD) with the twenty-four replica REMD simulation (ALA-24REMD) 
suggests that the larger ensemble takes longer to converge to the same 
precision than the smaller ensemble, although near quantitative results are 
obtained fairly quickly (Figure 4.6).  
Unfortunately, cumulative-type plots of convergence don’t always 
indicate that the ensemble has converged to the true value dictated by the 
force field if for some reason an individual replica becomes improperly trapped 
in a given conformation. A potentially more revealing test of convergence is 
found by plotting the RMSD profile of each replica trajectory prior to sorting 
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the data by temperature. In an ideal scenario, a converged REMD ensemble 
would consist of replicas which each traverse temperature space many times 
and therefore, over the course of a long simulation, would sample identical 
conformational space. Thus, the RMSD profile of each replica would be 
identical to one another. Nearly complete convergence of the replica RMSD 
profiles can be qualitatively demonstrated for the REMD simulations of alanine 
dipeptide (Figure 4.7) and we suggest such plots should be regularly included in 
publications. As we show later in the results for the RNA system, replicas which 
become conformationally trapped are easily spotted using this method.  
To quantify the conformational distribution of the alanine dipeptide 
simulations, the phi/psi torsion space of alanine dipeptide was divided into six 
regions (Figure 4.8, left) and the percent occupancy was calculated (Table 
4.3). The regions were identified by locating the minima (which correspond to 
regions of highest density) in a population based free energy plot of the phi/psi 
space (Figure 4.8, right). A comparison of the conformational populations 
between the conventional MD simulations (ALA-NVT, ALA-NPT) and the 
traditional REMD simulations (ALA-10REMD, ALA-24REMD) suggests that the two 
approaches yield very similar conformational results (Table 4.3). Also, the use 
of constant pressure or constant volume does not seem to significantly affect 
the results for conventional MD. Additionally, it appears that REMD with ten 
replicas and a maximum temperature of 398 K (ALA-10REMD) yields similar 
results to the twenty-four replica REMD with a maximum temperature of 600 K 
(ALA-24REMD). It is interesting to note that the REMD methods appear to 
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sample the rare F conformation more frequently than conventional MD. This 
may suggest that that the conventional MD simulations require more simulation 
time than was collected to adequately sample the F conformation and that 
REMD efficiently traverses the energy barriers to this conformation.  
When performing R-REMD simulations, in which a predefined reservoir 
quickly drives convergence of the REMD ensemble, the size and conformational 
diversity of the reservoir is an important concern. To understand how the 
composition of the reservoir affects the results, we examined a variety of 
reservoir sizes and compositions and report two examples here. The first, used 
in the ALA-R-REMD-L simulation, was a larger reservoir and consisted of 4764 
frames collected every 10 ps from a 47 ns simulation at 398 K. Comparison of 
the RMSD profile of this reservoir with the 397.7 K temperature replica from 
the ALA-10REMD simulation suggests that the reservoir is a reasonable 
approximation of a converged ensemble at 398 K, although its profile is not 
smooth due to the relatively small number of frames used (Figure 4.9). Using 
this reservoir, the ALA-R-REMD-L simulation generates a conformational 
ensemble at 300 K very similar to those observed using traditional REMD (Table 
4.3).  
We also studied a much smaller reservoir (ALA-R-REMD-S), containing 538 
artificially selected frames from the larger reservoir, in which structures from 
each of the three RMSD profile maxima are present but not at the correct 
relative frequencies (Figure 4.9). The resulting conformational distribution at 
300 K from the ALA-R-REMD-S simulation is perturbed slightly relative to the 
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other REMD and R-REMD simulations (Table 4.3), yet the small difference 
suggests that the R-REMD method is fairly robust at recovering the correct 
conformational frequencies even when the reservoir is sparse and non-
Boltzmann weighted. 
The R-REMD method offers significant savings in computational resources 
over traditional REMD. An even greater savings can potentially be found in the 
previously published TIGER2 method (38). Briefly, the TIGER2 method involves 
a small number of replicas for which a subset are rapidly heated from the 
baseline temperature to a higher sampling temperature and after a brief period 
rapidly quenched and equilibrated back to the baseline temperature. Following 
this heating and quenching cycle, the replicas are exchanged with the baseline 
replica with a probability based on the Metropolis criterion. The heating step 
allows the system to rapidly overcome energy barriers at high temperatures 
and the quenching step allows for replica exchange to occur at a reasonable 
rate at the baseline temperature. The TIGER2 algorithm is not implemented in 
AMBER, yet its simplicity makes using a wrapper script feasible, which is the 
approach we took. After testing our implementation of TIGER2, it was 
immediately clear that the equilibration period following the quenching step 
had a large effect on the exchange probability. We tested three quench-
equilibration periods, 1, 2, and 5 ps, which resulted in exchange success rates 
of 0.066, 0.277, and 0.475, respectively (corresponding to ALA-TIG-1, ALA-TIG-
2, and ALA-TIG-3). The conformational distribution of the TIGER2 simulations is 
similar in the overall trend to the other methods tested, yet there is a 
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noticeable difference in the frequency of the B and F conformations (Table 
4.3). It is not clear what causes this difference and further investigation will be 
necessary to understand the discrepancy. For this reason the TIGER2 method 
was not used to investigate the larger and more complex RNA system.  
4.4.2 rGACC RNA conformational analysis 
As part of an overall effort to improve RNA force fields, we wanted to 
focus computational efforts on a minimal RNA system for which conformational 
convergence could be quickly obtained and experimental data were available. 
The rGACC RNA has previously been studied in solution using NMR and in 
simulation using other force fields (39). Although it is very small, it still 
populates (at least two) A-form-like conformations and is therefore an ideal 
test case. The difficulty with using conventional MD simulations is that 
conformational convergence at the temperature of interest, even with the 
latest accelerated hardware, is difficult to achieve. We performed a 5 μs 
simulation at 300 K (RNA-NPT) and the atomic RMSD versus time plot indicates 
that only a few transitions occur between the major conformations on that 
timescale (Figure 4.10, top).  
Identification of four major conformations was performed by clustering 
and a representative structure of each is shown in Figure 4.11 in both 
molecular graphics and simplifying cartoon. Additional conformations were 
identified other than the four described here, but due to their population 
frequencies being 3% or less, they were not studied further in great detail. 
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Quantitative frequencies of the four conformations are given in Table 4.4. The 
most populated conformation in the RNA-NPT simulation, a non-A-form 
conformation which we term the “Intercalated structure,” does not fit the NMR 
data and was also observed to dominate a microsecond timescale simulation 
using the modified force field by Yildirim et al. (39). The next most populated 
conformations, termed the “NMR Minor” and “NMR Major,” are consistent with 
the NMR data as their names suggest and are essentially A-form structures. 
However, Yildirim et al. concluded that the NMR Major structure should 
dominate in solution with a small fraction of the NMR Minor structure present 
as well (39). In contrast to the experimental results, we observed a greater 
frequency of the NMR Minor structure compared to the NMR Major structure. 
The fourth structure, which was not described in the previous computational 
study of rGACC but was reported in a recent study of rCCCC (62), is termed the 
“Inverted” structure. It is a non-A-form conformation and is also not consistent 
with the observed NMR data.  
At 5 μs of conventional MD, the RNA-NPT simulation is still not converged 
enough for reliable force field comparison purposes. Even at 100 ns/day 
simulation speeds, attainable through use of GPU accelerated simulations, this 
simulation required 50 days to complete. Thus a more convenient, reliable, and 
cost effective method for studying the conformational landscape of complex 
structures is of interest. REMD simulations provide an attractive alternative. By 
coupling high temperature simulations which traverse energy barriers quickly 
with low temperatures simulations at experimentally relevant conditions, a 
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converged conformational ensemble is expected to be obtained quicker than by 
conventional MD alone (63). REMD is typically performed with implicit solvent 
because the number of replicas increases with the size of the system. 
Unfortunately, as of present, RNA simulations generally do not behave well in 
implicit solvent. To demonstrate this, we performed a 500 ns per replica REMD 
simulation in GB solvent using six replicas spanning a temperature range from 
277-463 K. At lower temperatures, the RNA nearly exclusively adopts the 
Inverted conformation whereas at the maximum temperature the RNA is largely 
unstructured (Figure 4.12). These results are consistent with our previous 
experience with RNA simulations in implicit solvent (unpublished) and suggest 
that explicit solvent is necessary for (even crudely accurate) simulations in the 
foreseeable future.  
To evaluate the performance of explicitly solvated REMD simulations, we 
performed three simulations: one 2 μs per replica timescale simulation using 
GPU acceleration (RNA-REMD-1) and two shorter, 400-500 ns per replica 
simulations using traditional CPU hardware (RNA-REMD-2 and RNA-REMD-3). 
Inspection of the RMSD versus time plot for RNA-REMD-1 suggests that frequent 
conversion between the four major conformations occurs over the course of the 
simulation (Figure 4.10, bottom). Comparison of the RMSD profile at 277 K for 
the three traditional REMD simulations reveal the difficulty in obtaining 
converged results (Figure 4.13). For instance a large peak at an RMSD value of 
4.0 Å is observed in the RNA-REMD-2 simulation but is much smaller in the 
other two simulations. The corresponding structure to this peak (Figure 4.14) is 
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not one of the previously mentioned conformations. Although it is present in 
low frequencies in the other REMD simulations it seems to dominate the RNA-
REMD-2 simulation. A small number of replicas are the main contributors to the 
overpopulation of this conformation in the ensemble and those replicas remain 
trapped for significant time periods despite regularly traversing the complete 
temperature space (Figure 4.15). This problem may be exacerbated by a short 
exchange attempt interval which will tend to reduce the average duration a 
replica stays at a given temperature. If a conformational transition requires 
some minimum time to proceed and also requires a high temperature to make 
traversal of an energy barrier more likely, a short exchange attempt interval 
may cause the replica to stay conformationally trapped. Extending the 
exchange attempt interval and/or increasing the number of target 
temperatures intervals above 398 K may alleviate this problem. 
As we mentioned in the results for alanine dipeptide, a convenient 
method to examine REMD ensemble convergence is to study the replica RMSD 
profiles for the ensemble data sorted by replica rather than sorted by 
temperature. In the ideal case, a converged REMD ensemble will generate an 
identical curve for each replica. We demonstrate the tendency towards a 
converged RMSD profile in Figure 4.16. At 200 ns, the replica RMSD profiles are 
dispersed and a consensus profile is difficult to distinguish. By the end of the 2 
μs simulation, the RMSD profiles are much more consistent although a few 
outliers remain, suggesting that longer simulation is required for complete 
convergence. A comparison can also be made between the three traditional 
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REMD simulations (Figure 4.17). These results also suggest that the 2 μs 
simulation (RNA-REMD-1) is closer to convergence than the shorter simulations 
(RNA-REMD-2 and RNA-REMD-3), although a single consensus profile is still not 
achieved.  
The conformational landscape of the rGACC structure is much more 
complicated than alanine dipeptide and cannot easily be represented by the 
equivalent of a phi/psi plot. Instead we used principal component analysis to 
identify the primary motional modes of the RNA in the RNA-REMD-1 simulation 
(Figure 4.18A,B). The division of clustering along these PCA axes can be 
visualized (Figure 4.18C) and a population based free energy plot reveals the 
relative minima (Figure 4.19). These plots show that the two conformations 
consistent with NMR data, NMR Major and NMR Minor, are nearly overlapping in 
the primary motional axes whereas the two non-A-form conformations are 
distant from the NMR structures, suggesting a force field problem which leads 
to incorrect population sampling. 
The results of traditional REMD suggest that even on fairly long 
timescales by current standards and at significant resource cost, 
conformational convergence is not achieved. Thus, this is not a very feasible 
method for force field development which requires multiple such simulations 
run in a linear fashion. Given the success we found with R-REMD simulations of 
alanine dipeptide, we decided to investigate whether the method was also 
feasible for larger more complicated systems like rGACC. To generate the 
reservoir, a 1.4 µs simulation of the RNA at 398 K was performed saving frames 
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every 10 ps (RNA-398). A plot of the RMSD versus simulation time reveals that 
all four conformations are sampled many times during the simulation and a 
smooth RMSD profile is generated (Figure 4.20). This is an important 
observation because it shows that conventional MD at 398 K does not exhibit 
the conformational trapping behavior which was observed for the traditional 
REMD approach. As we demonstrate below, the R-REMD method also does not 
suffer from conformational trapping due to the frequent exchange with this 
high temperature reservoir.  
Three independent R-REMD simulations were run using this reservoir: 
RNA-R-REMD-1 (205 ns/replica), RNA-R-REMD-2 (160 ns/replica), and RNA-R-
REMD-3 (250 ns/replica). Analysis of the RMSD profile for these simulations 
shows that the conformational detail at 277 K emerges from the smooth, 
distinctly different reservoir profile at 398 K (Figure 4.21). Inspection of the 
replica RMSD profiles (sorted by replica, not temperature) for the three R-REMD 
simulations suggests improved convergence (Figure 4.22) as do the similar 
quantitative results obtained from cluster analysis (Table 4.4). Comparison of 
the quantitative clustering results for the R-REMD method at three 
temperatures, 277, 299, and 328 K, reveals an interesting trend. Increasing the 
temperature significantly reduces the frequency of the two NMR consistent 
structures but not the non-A-form structures. Only a small decrease is seen for 
the Intercalated structure and an increase is observed for the Inverted 
structure. This suggests that the entropic component of the free energy favors 
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the non-A-form structures more than the NMR structures and thus this 
preference increases with temperature.  
In order to test how the composition of the reservoir affects the R-REMD 
results for the RNA system, we performed an additional simulation with a much 
smaller reservoir. This simulation, RNA-R-REMD-S, contained only 10,000 
frames from the first 100 ns of the RNA-398 simulation. In this time period, 
three of the four major conformations were sampled including the 
Intercalated, NMR Minor, and NMR Major (Figure 4.20). The Inverted 
conformation was not sampled until ~150 ns and thus was not present in this 
reservoir. As expected, quantitative conformational analysis of the RNA-R-
REMD-S simulation shows that the Inverted conformation is not present in any 
significant amount (Table 4.4). This underscores the importance of having 
representatives from each significantly populated structural class present in 
the R-REMD reservoir.  
4.4.3 Comparison of rGACC RNA simulation data with NMR data 
Given that the R-REMD simulations appear to be a reliable method for 
obtaining an accurate conformational data about rGACC in simulation, we 
decided to make a deeper comparison between the published NMR data and the 
simulation data (specifically for RNA-R-REMD-3). Two easy comparisons include 
the sugar pucker and base orientation preferences. Values at three different 
temperatures for these metrics are given in Table 4.5.  
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The sugar pucker values observed in simulation are consistent with the 
NMR measurements for the first three residues, while residue C4 significantly 
underpopulates the C3’-endo conformation compared to experiment at 277 K. 
At 328 K, both residues G1 and C4 are out of the experimental range, with G1 
overpopulating C3’-endo and C4 still underpopulating C3’-endo. The deviation 
of the simulation sugar pucker from experiment at C4 is likely due to the 
overpopulation of the NMR Minor structure, which prefers C2’-endo at C4. 
Quantitative values for the other metric of interest, base orientation, were not 
obtained in the experimental publication; however the NOESY spectrum 
indicated that all four residues preferred the anti conformation at 275 K. 
Simulation values are consistent with this observation, with the possible 
exception of residue G1. It seems likely that a stronger NOE would have been 
observed if the anti/syn ratio was 64/36, as was observed in simulation. Taken 
together, these two metrics offer only a weak indication that the force field is 
incorrectly modeling the solution structure, primarily by highlighting the under-
population of the C3’-endo sugar pucker state by residue C4. 
In order to make a more detailed comparison with the NMR data, we 
investigated whether any of experimentally observed NOEs were violated. To 
study this, the r6-averaged distances for all possible NOE pairs were calculated 
for the RNA-R-REMD-3 simulation at 277 K. Of the 21 experimentally supported 
atom distance restraints, only one pair was in violation: atoms G1 H8 and A2 
H8. The experimental restraint lower and upper bounds are 2.0 – 5.0 Å, while 
the simulation r6-average is 5.3 Å. (Note: the lower/upper bounds listed for this 
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restraint in the publication SI were written as 2.0 – 10.0 Å, but this was done to 
“search broader conformational space” during annealing. In fact, the NOESY 
data indicate that the upper bound should be less than 5.0 Å (39).) A violation 
rate of 1/21 would ordinarily be fairly high; however, in this case it leaves us 
with just one data point. Thus it is important to inspect atom pairs for which 
the simulation results would predict an NOE signal but where none is observed 
experimentally. This approach was noted in the previous computational study 
when discussing the non-A-form Intercalated structure (39). We identified 
fifteen atom pairs for which the r6-average value was 5.0 Å or less, but for 
which no NOE signal was identified by NMR (Table 4.6). A visual depiction of 
these predicted atom pairs, overlaid on both the NMR Major and Intercalated 
conformations, as well as the single restraint violation, are shown in Figure 
4.23.  
These data strongly suggest that the force field overpopulates the non-
A-form structures. We acknowledge that even if the non-A-form structures 
were truly present in solution, it is unlikely that NOE signals would be 
observable for all fifteen identified atom pairs due to the limitations of 
experimental studies. However, we do show that there exist many atom pairs 
for which an NOE signal should arise if the non-A-form conformation is really 
present. Taken together, our comparison to the published NMR data suggests 
that the ff12SB force field requires further improvements in order to 




In this work we have demonstrated a tractable method for reliable 
generation of conformational ensembles from explicitly solvated simulations. 
This represents a necessary step towards cost-effective force field 
development of RNA. Conventional MD, even with advances in accelerated 
hardware, is still not a feasible method for research that requires both quick 
turnaround and extensive sampling of a rugged conformational landscape. 
REMD, which has been one of the traditional solutions to this problem, is not 
nearly as cost effective when explicit solvent is required as is the case for most 
RNA simulations. In addition, we have shown that even REMD simulations of 
significant length (2 μs) may be slow to converge for certain systems. In other 
words, although traditional REMD has improved convergence with respect to 
conventional MD, that does not mean it is guaranteed to converge. Thus we 
have turned to the R-REMD method, in which a pregenerated, high temperature 
reservoir drives the convergence of a REMD ensemble. At high temperatures, 
the rugged conformational landscape is much more easily traversed than at 
lower temperatures (compare Figure 4.10, top and 4.20) and thus the reservoir 
is quickly and relatively cheaply generated. Use of the reservoir reduces the 
simulation time required for the resource intensive REMD step and thus leads to 
converged results which are cheaper than traditional REMD. It should also be 
mentioned that the aggregate simulation time for all replicas is far less than 
traditional REMD and comparable to that of the brute force conventional MD, 
and thus is a more efficient use of computational resources. 
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Care must be used when employing R-REMD method. For example, the 
reservoir must sufficiently sample the energy landscape in order to include all 
of the major conformations. We observed that a deliberately small reservoir 
completely eliminated one of the major rGACC conformations. Despite this, a 
perfectly converged reservoir does not seem to be necessary. We showed that 
a reservoir with skewed populations (albeit one with that included all major 
conformational classes) only slightly modified the conformational distribution 
at the baseline temperature. Finally, we suggest it is necessary to plot RMSD 
profiles for the data sorted by replica, rather than temperature, in order to 
determine how much simulation time is required for convergence. Significant 
discrepancies between these profiles can indicate that the ensemble has not 
yet converged and might contain trapped replicas.  
After we determined that the R-REMD method was a reliable method for 
generating consistent data regarding the conformational landscape of rGACC, 
we were able to make specific comparisons with the published NMR data. 
These comparisons suggest that the ff12SB force field overpopulates non-A-
form conformations for the rGACC tetramer. The source of this error is not 
immediately clear, although we suspect that refinements to the sugar pucker 
torsions or backbone torsions may improve the results. In addition to studying 
force field refinements, we can also easily study the effect of various water 
models, salt composition, and salt concentration on the results. The R-REMD 
method also holds promise for studying flexible portions of much larger 
molecules. For instance, a noncanonical region of a larger RNA could be studied 
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by generating a high temperature reservoir in which base pair restraints are 
used to prevent complete unfolding. The resulting R-REMD simulation would 
allow a focus on the conformational landscape of regions where the current 
force field is flawed (i.e., noncanonical regions), while limiting unfolding in 
helical regions where the force field behaves better. This approach may also be 










Figure 4.1.  Molecules investigated in this research: alanine dipeptide (left), 







Table 4.1. Simulations performed in this work. 
 
Simulation ID Simulation Details Temp. Rep. Length 
ALA-NVT NVT, dt=2fs, cwi=1ps  300 1 100 
ALA-NPT NPT, dt=2fs, cwi=1ps  300 1 314 
ALA-398 NVT, dt=2fs, cwi=10ps 398 1 47 
ALA-10REMD REMD, NVT, dt=2fs, eai=0.2ps, cwi=1ps 300 - 398 10 138 
ALA-24REMD REMD, NVT, dt=1fs, eai=1ps, cwi=1ps 300 - 600 24 96 
ALA-R-REMD-S R-REMD, NVT, dt=2fs, eai=0.2ps, cwi=1ps, r=538 300 - 398 10 240 
ALA-R-REMD-L R-REMD, NVT, dt=2fs, eai=0.2ps, cwi=1ps, r=4764 300 - 398 10 84 
ALA-TIG-1 TIGER2, NVT, dt=1fs, eai=3ps, cwi=1ps 300 - 600 4 75 
ALA-TIG-2 TIGER2, NVT, dt=1fs, eai=4ps, cwi=1ps 300 - 600 4 100 
ALA-TIG-3 TIGER2, NVT, dt=1fs, eai=7ps, cwi=1ps 300 - 600 4 105 
RNA-NPT NPT, dt=2fs, cwi=2ps  300 1 5000 
RNA-398 NVT, dt=2fs, cwi=10ps 398 1 1405 
RNA-REMD-GB REMD, dt=2fs, eai=0.2ps, cwi=1ps 277 - 463 6 500 
RNA-REMD-1 REMD, NVT, dt=2fs, eai=1ps, cwi=1ps 277 - 396 24 2010 
RNA-REMD-2 REMD, NVT, dt=2fs, eai=0.2ps, cwi=1ps 277 - 396 24 500 
RNA-REMD-3 REMD, NVT, dt=2fs, eai=0.2ps, cwi=1ps 277 - 396 24 400 
RNA-R-REMD-S R-REMD, NVT, dt=2fs, eai=1ps, cwi=1ps, r=10000 277 - 396 24 46 
RNA-R-REMD-1 R-REMD, NVT, dt=2fs, eai=1ps, cwi=1ps, r=140510 277 - 396 24 205 
RNA-R-REMD-2 R-REMD, NVT, dt=2fs, eai=1ps, cwi=1ps, r=140510 277 - 396 24 160 
RNA-R-REMD-3 R-REMD, NVT, dt=2fs, eai=1ps, cwi=1ps, r=140510 277 - 396 24 250 
 
Note: Simulation IDs beginning with “ALA-“ contained one alanine dipeptide 
molecule solvated in TIP3P water. Those beginning with “RNA-“ contained 
one rGACC molecule, three Na+ counterions, and TIP3P water (with the 
exception of RNA-REMD-GB which used implicit solvent). Column titles and 
abbreviations are as follows: Temp.: the temperature range covered in the 
simulations, Rep.: the number of replicas used, Length: the per replica 
simulation time length in nanoseconds, NVT: constant volume/temperature, 
NPT: constant pressure/temperature, REMD: replica exchange molecular 
dynamics, R-REMD: reservoir replica exchange molecular dynamics, dt: the 
simulation time step, cwi: the trajectory coordinate writing interval, eai: 






Table 4.2.  Temperatures used for REMD and R-REMD simulations. 
 
ALA-24REMD 
300.00 309.83 319.91 330.22 340.79 351.63 362.74 374.11 385.76 397.70 409.94 422.47 
435.33 448.51 462.02 475.87 490.06 504.60 519.52 534.83 550.53 566.64 583.14 600.07 
                        
ALA-10REMD, ALA-R-REMD-S, ALA-R-REMD-L 
300.00 309.83 319.91 330.22 340.79 351.63 362.74 374.11 385.76 397.70     
                        
All Explicit Solvent RNA REMD or R-REMD 
277.00 281.30 285.70 290.20 294.70 299.40 304.00 308.80 313.60 318.50 323.50 328.60 
333.70 338.90 344.20 349.60 355.10 360.70 366.30 372.00 377.90 383.80 389.80 395.90 
                        
RNA-REMD-GB 
277.00 308.16 342.06 379.00 419.19 462.87             
 
Note:  All temperatures are given in Kelvin.  The distributions were obtained 
from an online generator at http://folding.bmc.uu.se/remd/.  Refer to 
Table 4.1 for more information about each simulation ID, noting that the 
number refers to the number of replicas and “S” and “L” for the R-REMD 








Figure 4.2. RMSD versus time at 277 K for the first 100 ns of the RNA-REMD-3 
simulation.  The plot demonstrates that about 50 ns are required for the 








Figure 4.3.  RMSD profile for the 300 K simulation data from the following 
alanine dipeptide simulations: ALA-NVT (solid black), ALA-NPT (dashed 
black), ALA-10REMD (solid red), ALA-24REMD (dashed red), ALA-R-REMD-L 
(solid blue). Tight overlap in the profiles suggests that these simulations 
explore very similar RMSD space. The colored arrows indicate RMSD profile 
points studied for the time convergence displayed in Figure 4.5. The points 








Figure 4.4.  Convergence of the RMSD profile of ALA-NVT.  The cumulative 
RMSD profiles, plotted each nanosecond of the 100 ns simulation, is given 








Figure 4.5.  Convergence of alanine dipeptide RMSD profile maxima versus 
simulation time at 300 K for the following simulations: ALA-NVT (solid), ALA-
10REMD (dashed), ALA-R-REMD-L (dotted). Colors correspond to the three 
RMSD profile maxima observed in Figure 4.3 at the following values: 0.16 
(black), 0.78 (red), 1.44 Å (blue). Only the first 50 ns of each simulation are 








Figure 4.6.  Convergence of alanine dipeptide RMSD profile maxima versus 
simulation time at 300K for the following simulations: ALA-10REMD (solid) 
and ALA-24REMD (dashed)   Colors correspond to the three RMSD profile 
maxima observed in Figure 4.2 at the following values: 0.16 (black), 0.78 
(red), 1.44 Å (blue).  The vertical axis maximum value was set to 8% for 







Figure 4.7.  Overlay of the ten replica RMSD profiles for the ALA-10REMD 
simulation.  Convergence of the simulation is indicated by the tight overlap 
of the RMSD profiles suggesting that all replicas have sampled similar RMSD 
space.  Temperature sorting was not performed when generating this plot 









Figure 4.8.  Identification of alanine dipeptide phi/psi conformational 
divisions. (Left) Six regions were identified and labeled A-F. (Right) 
Population based free energy plot based on phi/psi dihedral angles for the 
ALA-10REMD simulation at 300 K. Free energy estimates are calculated using 





Table 4.3.  Alanine dipeptide conformational distribution at 300 K for 
simulations in this work. 
 
  Alanine Dipeptide Conformational Frequency (%) 
Simulation A B C D E F 
ALA-NVT 12.3 (0.2) 56.6 (1.9) 0.0 (0.0) 4.1 (0.1) 27.0 (1.7) 0.0 (0.0) 
ALA-NPT 12.2 (0.0) 56.9 (1.2) 0.2 (0.1) 4.0 (0.1) 25.1 (0.6) 1.7 (0.3) 
ALA-10REMD 11.3 (0.2) 54.2 (0.1) 0.6 (0.1) 3.8 (0.0) 26.0 (0.3) 4.1 (0.7) 
ALA-24REMD 11.8 (0.5) 55.6 (0.1) 0.3 (0.1) 3.9 (0.0) 25.5 (0.3) 3.0 (0.7) 
ALA-R-REMD-S 13.3 (0.2) 58.9 (0.1) 0.1 (0.0) 3.4 (0.0) 23.0 (0.1) 1.2 (0.2) 
ALA-R-REMD-L 11.6 (0.0) 54.9 (1.0) 0.3 (0.0) 4.1 (0.2) 26.3 (1.2) 2.9 (0.5) 
ALA-TIG-1 11.3 (0.7) 49.5 (2.9) 0.9 (0.3) 4.2 (0.2) 28.9 (1.5) 5.2 (2.1) 
ALA-TIG-2 12.3 (0.8) 45.9 (0.1) 1.3 (0.2) 4.8 (0.4) 28.6 (1.9) 7.1 (2.7) 
ALA-TIG-3 11.3 (0.2) 46.0 (2.0) 2.0 (0.5) 4.7 (0.1) 27.8 (0.2) 8.2 (2.0) 
 
Note: Letters A-F indicate regions of the phi/psi space indicated in Figure 
4.8, left. Given in parentheses is a crude approximation of error obtained by 
comparing the average frequency values from the first and second halves of 








Figure 4.9.  RMSD profiles for the following simulations:  ALA-10REMD at the 
397.7 K temperature level (black), reservoir of ALA-rREMD-L (red), reservoir 
of ALA-rREMD-S (blue bars).  The ALA-rREMD-L reservoir (red) contains 4764 
frames from a 47 ns simulation at 398 K, whereas the ALA-rREMD-S reservoir 
(blue bars) contains 538 artificially selected frames from the larger ALA-
rREMD-L reservoir.  Bars are used to depict the ALA-rREMD-S reservoir due to 







Figure 4.10.  RMSD analysis of the RNA-NPT (top) and the RNA-REMD-1 
(bottom) simulations. The data for RNA-REMD-1 are taken exclusively from 
the 277 K temperature level. The colored regions correspond to the four 
most populated conformational clusters depicted in Figure 4.11 as follows: 
Intercalated (red), NMR Minor (green), NMR Major (blue), Inverted (yellow), 







Figure 4.11.  Stereoview and cartoon representation of the representative 
structures for the four most populated conformational clusters of the RNA-
NPT simulation. Each structure is labeled with a reference name and color 





Table 4.4.  Conformational frequency of the RNA simulations determined by 
cluster analysis. 
 
  rGACC Conformational Frequency (%) 
Simulation ID Intercalated NMR Minor NMR Major Inverted 
RNA-NPT1 16.0 (0.3) 12.9 (0.7) 9.2 (0.4) 8.4 (0.1) 
RNA-3982 6.2 (0.4) 3.5 (0.3) 3.1 (0.1) 7.1 (0.5) 
RNA-REMD-GB -- -- -- -- -- -- 92.9 (0.7) 
RNA-REMD-1 24.5 (0.9) 15.9 (0.7) 11.8 (0.6) 7.6 (0.0) 
RNA-REMD-2 24.2 (1.2) 10.5 (1.0) 8.8 (0.5) 9.9 (0.1) 
RNA-REMD-3 18.8 (0.9) 16.3 (1.0) 13.1 (0.5) 7.3 (0.1) 
RNA-rREMD-S 29.4 (0.1) 28.3 (1.1) 12.0 (0.2) -- -- 
RNA-rREMD-1 18.7 (0.3) 15.5 (0.7) 13.1 (0.4) 11.3 (0.1) 
RNA-rREMD-2 18.5 (0.1) 15.3 (1.0) 13.6 (0.1) 10.9 (0.0) 
RNA-rREMD-3 18.7 (0.5) 14.6 (0.7) 14.0 (0.4) 10.2 (0.1) 
 
Note: The four conformational categories are structurally depicted in Figure 
4.6. Data shown are for the 277 K temperature level, except for the RNA-
NPT and RNA-398 simulations, for which the temperature is indicated 
(below).  An error estimate is given in parentheses which corresponds to the 
standard deviation of five independent clustering calculations. 1Simulation 
performed at 300 K. 2Simulation performed at 398 K. The “-- --“ indicates 









Figure 4.12.  RMSD profile for RNA-REMD-GB at 277 K (black), 308 K (red), 
and 462 K (blue).  The two lowest temperature profiles (black and red) 
exclusively adopt the Inverted conformation (refer to Figure 4.11).  The 








Figure 4.13.  RMSD profile for data collected at 277 K from the following 









Figure 4.14.  Molecular graphics stereoview of the additional RNA 
conformation which forms an RMSD profile peak at 4.0 Å in the RNA 
simulations from this work.  The conformation appears to dominate some 
replicas in the traditional REMD simulations.  It is also present in both the 








Figure 4.15.  An example of a trapped replica in the RNA-REMD-2 
simulation.  (Top) RMSD versus time plot for replica 16.  The primary 
conformation sampled, around 4.0 Å, is depicted in Figure 4.14.  These data 
come directly from the replica trajectory (prior to temperature sorting) and 
thus include all the temperatures from the simulation.  To demonstrate this, 
we analyzed the target temperature of the replica during time period 
indicated by the red line segment.  (Bottom) The target temperature of 
replica 16 from RNA-REMD-2 during the simulation time period indicated in 
the top plot.  The replica regularly moves between all target temperatures 








Figure 4.16.  Overlay of the twenty-four replica RMSD profiles for the RNA-
REMD-1 simulation after 200 ns (black) and for all the data (red).  
Temperature sorting was not performed when generating this plot and thus 







Figure 4.17.  Overlay of the twenty-four replica RMSD profiles for the 
following simulations: RNA-REMD-1 (top), RNA-REMD-2 (middle), RNA-REMD-3 
(bottom). A fully converged REMD ensemble should produce an identical 
curve for each replica and thus disorder in the plot indicates that the 







Figure 4.18.  PCA analysis of the RNA-REMD-1 simulation at 277 K. 
Stereoview depiction of the motion described by the first (A) and second (B) 
eigenvectors determined by principal component analysis. (C) Distribution of 
the simulation data along the first two eigenvectors identified by PCA. 
Colored regions correspond to the four most populated conformational 
clusters depicted in Figure 4.11 as follows: Intercalated (red), NMR Minor 








Figure 4.19.  Conformational analysis of the RNA-REMD-1 at 277 K using a 
population based free energy plot.  Free energy estimates are calculated 








Figure 4.20.  Conformational analysis of the RNA-398 simulation.  This 
simulation was used to generate structures for the R-REMD simulations of the 
RNA. (Left) RMSD versus simulation time.  Colored regions correspond to the 
four most populated conformational clusters depicted in Figure 4.11 as 
follows: Intercalated (red), NMR Minor (green), NMR Major (blue), Inverted 









Figure 4.21.  RMSD profile at the 277 K temperature level for RNA-R-REMD-1 
(solid red), RNA-R-REMD-2 (dashed red), RNA-R-REMD-3 (dotted red) as well 
as the profile for the structural reservoir used in these simulations (which 








Figure 4.22.  Overlay of the twenty-four replica RMSD profiles for the 
following simulations: RNA-R-REMD-1 (top), RNA-R-REMD-2 (middle), RNA-R-
REMD-3 (bottom). The replica profiles for these R-REMD simulations seem to 







Table 4.5.  Sugar pucker and base orientation at three temperatures from 
the RNA-R-REMD-3 simulation. 
 
  277 K 299 K 328 K 
Residue % C3'-endo % Anti % C3'-endo % Anti % C3'-endo % Anti 
G1 91 (80-90) 64 89 (60-70) 57 84 (50-60) 48 
A2 81 (80-90) 96 79 (80-90) 94 76 (70-80) 92 
C3 87 (80-90) 98 84 (80-90) 98 80 (70-80) 97 
C4 52 (70-80) 99 50 (70-80) 99 49 (60-70) 99 
 
Note: In parentheses are the experimentally determined ranges for the sugar 
pucker determined by NMR at the following temperatures: 278, 298, and 328 
K (39). The base orientation, determined by NMR, was anti for all four 






Table 4.6.  NOEs predicted by the RNA-R-REMD-3 simulation at 277 K but not 
observed experimentally by NMR. 
 
Atom 1 Atom 2 r6 Avg. Int. Min. Maj. Inv. 
:3@H3' :4@H3' 2.9 2.6 2.8 4.8 5.0 
:3@H3' :4@H2' 2.9 4.8 2.9 6.1 6.5 
:1@H2' :3@H5 3.2 3.6 6.6 5.8 3.1 
:1@H5' :4@H2' 3.4 2.7 12.6 14.1 11.2 
:1@H8 :4@H3' 3.8 2.9 12.5 14.4 7.5 
:1@H2' :4@H5 3.8 6.3 13.6 8.4 2.6 
:1@H8 :4@H2' 3.9 3.2 12.1 13.9 6.7 
:1@H8 :3@H3' 4.5 3.2 12.2 11.7 8.5 
:1@H3' :3@H6 4.6 4.0 7.3 6.5 4.3 
:1@H8 :4@H6 4.7 3.5 14.1 11.9 6.7 
:1@H5' :4@H3' 4.7 4.5 12.9 14.6 10.6 
:1@H8 :4@H5 4.8 4.0 14.9 10.1 5.0 
:1@H8 :3@H2' 4.9 4.0 12.6 12.3 8.7 
:1@H8 :3@H6 4.9 4.2 9.6 8.9 8.5 
:1@H5'' :4@H2' 5.0 4.0 11.0 12.7 11.0 
 
Note: the first three columns indicate the atom pairs and the r6-averaged 
distances obtained from the simulation. The last four columns list the 
corresponding distance observed in the most populous representative 
structures which are depicted in Figure 4.11. Conformational abbreviations: 









Figure 4.23.  Stereo views of the simulation predicted NOEs (black lines) for 
RNA-R-REMD-3 at 277 K mapped onto the NMR Major conformation (top) and 
the Intercalated conformation (bottom). Only the NOEs for which the 
Intercalated conformation is the primary contributor are shown. The single 
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T. E., Šponer, J. i., and Otyepka, M. (2010) Performance of molecular 
mechanics force fields for RNA simulations: stability of UUCG and GNRA 
hairpins, J. Chem. Theory Comput. 6, 3836-3849. 
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 In this chapter, we summarize in a two-part fashion the research 
presented in Chapters 2 – 4. First, the significance of the research is evaluated 
in the context of current methods. Second, we discuss ongoing projects and 
consider the long term directions of RNA simulation research. 
5.1 Significance 
In Chapter 2, we have demonstrated that simulations can provide a 
robust tool for evaluating structural ensembles from NMR refinements. By 
studying two domain 5 variants of the group II intron, we revealed that 
traditional structure refinement procedures can mask restraint violations and 
structural artifacts. By performing a simulation, rather than selecting 
structures with the fewest restraint violations, a researcher can monitor the 
cumulative effect of the restraints within the context of a fully solvated energy 
potential. In the case of the ai5γ domain 5, three restraints were clearly 
responsible for creating an unphysical kink in the RNA structure. By monitoring 
such problematic restraints over the time course of the simulation, a dynamic 
analysis of the restraints can be considered. This type of end-stage refinement 
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of NMR ensembles, which includes sophisticated energetic analysis in the 
context of explicit solvent, will likely expand the range of molecules for which 
useful structural data can be obtained. 
We were able to make similar observations regarding the inhibitor bound 
HCV IRES using unrestrained simulations. Experience has taught us that the 
current AMBER RNA force field models with reasonable accuracy local 
conformational minima, but the relative weighting of each minima might be 
incorrect. The observation that nearly all of the simulations which started in 
the NMR conformation became unstable within just a few nanoseconds suggests 
that the NMR conformation is not near an energy minima. In contrast, the 
crystal conformation is clearly in an energy minima, as only very subtle changes 
in its structure occur during simulation. Additionally, we have shown that 
binding energy estimates based on implicit solvent energy terms yield incorrect 
results. As an alternative, the use of binding enthalpy, including explicit 
solvent, appears to be a better estimate of the total free energy. Neglecting 
entropy appears to be reasonable in this case due to the similarity of the 
ligands investigated. These results are some of the first for an RNA/small 
molecule complex and will be instructive for future research as the field grows. 
Despite the aforementioned utility, the AMBER RNA force field has 
additional room to improve. As mentioned earlier, RNA conformations may be 
sampled at improper frequencies. This is likely due to subtle force field errors. 
Unfortunately, determining the source of such problems has been difficult due 
to the extreme time and resource investment required to exhaustively sample 
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the available conformational space. Our investigation of the tetranucleotide 
rGACC appears to be ideal for this purpose. Its small size reduces the 
computational burden of advanced sampling techniques, yet it populates a 
diverse set of conformations for which many appear to be incorrectly favored 
by the force field. This combination of size and conformational richness allows 
us to evaluate emerging algorithms for simulation as well as develop and test 
new RNA force fields. 
5.2 Future Directions 
Based on the research presented here, a variety of near term follow-up 
projects can be considered. In addition to presenting these, many of which are 
already underway, we also speculate on the longer term direction of RNA MD 
simulations.  
The re-refinement research presented in Chapter 2 suggests that many 
published NMR ensembles could likely be improved by the use of restrained MD 
simulation in explicit solvent. This would be unnecessary if the NMR data 
defining positional and orientational restraints were dense enough that solvent 
representation and advanced force fields were unnecessary. Unfortunately it is 
often the case, especially for noncanonical regions of RNA, that the NMR data 
are somewhat underdetermined. In these situations, traditional NMR 
refinement techniques can produce unusual and pathological conformations. 
Of course, given the known limitations of RNA force fields, it is also true 
that if the NMR data are too sparse, even restrained simulations will give 
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anomalous results. Thus it would be of interest to study a well-determined RNA 
structure which maintains the correct geometry during restrained simulation 
but deviates significantly during unrestrained simulation. By selectively 
removing more and more restraints, thereby determining the “transition point” 
between well-behaved and un-behaved simulations, insight into force field 
flaws can be uncovered. Additionally, it is also likely the use of time-averaged 
distance restraints might produce a more realistic ensemble, especially in the 
case of highly flexible RNA. Such an approach has been used with small 
furanose models (1) and nucleic acid helices (2, 3). However, recent advances 
in simulation timescales would again make this approach interesting for 
systems such as an RNA tetranucleotide or small hairpin. The inherent 
flexibility in these latter systems would provide a more robust test of whether 
time-averaged restraints produce a more accurate ensemble than traditional 
refinement approaches. As force fields improve, significantly fewer 
experimental restraints will be required to generate an accurate 
conformational ensemble. Eventually, we envision the generation of refined 
models from simple two-dimensional structure maps of RNA. Explicitly solvated 
simulations would likely provide the final step in such a structure 
determination process. 
The study on inhibitor binding to the HCV IRES element in Chapter 3 has 
a variety of additional work already in progress. For example, despite the well-
behaved nature of the X-ray structure in simulation, certain aspects of that 
conformation are not reconcilable with the NMR data. A number of possible 
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explanations could account for this discrepancy, including multiple binding 
modes and alternate RNA conformations, and we are actively testing these 
hypotheses. Additionally, we are studying a variety of novel inhibitor structures 
in order to identify scaffolds which offer tighter binding than existing 
inhibitors. These studies represent some of the first steps in computer-aided 
drug design on RNA targets. Given the growing appreciation for the multi-
faceted roles of RNA in controlling cell processes, we anticipate growing 
interest in small molecule drugs targeting RNA. 
Finally, our work on enhanced sampling of a small RNA oligonucleotide in 
Chapter 4 has enabled us to quickly and quantitatively test new force field 
modifications. Quantitative results are critical because individual trajectories 
from conventional MD at laboratory temperatures require extraordinary 
simulation times to converge and can lead to misleading interpretations of the 
force field. We are currently testing a re-parameterization of the ribose sugar 
pucker based on comparison to reference quantum mechanical calculations. To 
build on this work, we will also investigate a variety of other tetranucleotide 
sequences and build a collaborative effort with NMR experimentalists in order 
to identify and correct simulation weaknesses. Additionally, we hope to use 
this sampling method with larger, more structured RNA. In order to avoid 
complete melting of the structure at high reservoir temperatures, base pair 
restraints will be used to limit unfolding. This approach will allow the detailed 
study of flexible loop and bulge regions without the associated cost of 
complete unfolding. Finally, given our thorough conformational analysis of the 
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rGACC tetranucleotide, we have begun testing emerging sampling methods 
including Hamiltonian replica exchange and multidimensional replica exchange. 
Through comparison with the data in Chapter 4, we can assess the suitability 
(and potential liabilities) of new sampling methods. 
MD simulations of RNA have improved in accuracy while advances in 
computational hardware are opening new timescales for active research. 
However, further room for improvement is still evident. In order to maximize 
the utility of these methods, deep collaborations need to be built between 
experimental and theoretical approaches. The cross-talk between both 
approaches will yield lasting insights into biomolecular structure and function. 
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